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PREFACE 
Foreword 
This is the summary of research over five years within different projects related to 
impedance-based biomedical sensors. An introduction to this technology is given in CH1, 
leading to the general aim of the work given in CH2. The content is then divided into three 
parts: electrodes, instrumentation and signal processing, which are introduced in CH1. For a 
gradual insight into this work, it is advised to first continue with CH3 on instrumentation, and 
then go on to CH4 and CH5. These are the main chapters which summarize all the 
technological papers with an introduction to the topic followed by specific problems, aims, 
results, discussion and conclusion. In order to discuss the potential for clinical benefit of the 
technology, a whole chapter (CH6) is dedicated to the clinical perspective of the biomedical 
sensors including the clinical and pre-clinical papers. In CH7, some of the ongoing and 
unpublished related work is mentioned before the general discussion and conclusion is given 
in CH8. Among the included papers, papers I, II, III and VIII are related to instrumentation, 
papers IV, V and VI are related to electrodes, papers VII, IX, X and XI are related to signal 
processing, and papers XII, XIII and XIV are related to clinical or pre-clinical testing. A 
poster relevant to the clinical use of one of the biomedical sensors is attached as an appendix.  
 
Timeline, projects and funding 
This work started with the continuation of the Author’s Master’s degree project where a 
prototype instrumentation was developed for measurement of sweat activity [Tronstad 2005]. 
Since then, the development of this sensor has continued towards the final goal of clinical use. 
In 2007, the further developed sensor was presented at the ICEBI XII conference in Graz. The 
Author was then motivated to pursue a doctoral degree, and a paper was submitted to 
Physiological Measurement later the same year. A 3-year hyperhidrosis project was described 
by Sverre Grimnes, Erik Fosse and Anne-Lene Krogstad at Oslo University Hospital (OUS), 
but funding was not granted. At this time, the Author was funded on 40% salary from 
BioGauge A/S only. In 2008, the Author was included in a bioimpedance sensor project led 
by Håvard Kalvøy at the Department of Clinical and Biomedical Engineering, OUS, and 
partly funded by this project together with 20% consultancy work for Alertis Medical ASA. In 
2009, the Author was 80% funded as a research fellow in a biomedical sensor project led by 
Alertis Medical ASA, which had 50% funding from the Norwegian Research Council. Due to 
bankruptcy, this lasted only a year, and the Author was offered a 100% temporary position for 
2010 at the Department of Clinical and Biomedical Engineering, with 50% time for research 
and development. A 50% position was extended in 2011 for clinical research assistance and 
completion of the doctorate work. Since January 2012, the Author has worked in a full-time 
position at the Department of Clinical and Biomedical engineering. Hence, from 2007 until 
2012, the Author has jumped between several projects due to funding, but the research and 
development has always been on impedance-based biomedical sensors for clinical use, which 
is the theme of this thesis.  
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1.0 GENERAL INTRODUCTION 
 
For a clear understanding of the topic of this work, it is necessary to first give a definition of a 
biomedical sensor.  To begin with, consider an object with a property of interest, and a tool 
which can be applied in order to sense this property. In this context, the object is the human 
body and the tool is called a sensor. A sensor is a mediator able to convert one or more 
measurands (properties) or physical variables into an equivalent signal variable of another 
type of quantity within a frame of a given unity [Pallàs-Areny & Webster, 2001, pp.3-4]. 
When the sensor is used for purposes within the fields of biology or medicine, the sensor is a 
biomedical sensor. Grimnes and Høgetveit 2011 gave the following definition of a biomedical 
sensor: A biomedical sensor is a device converting any signal related to the science of any 
living tissue into other quantities, usually an electrical signal, and thereby representing a 
connection between a biomedical and a recording system. This work concerns biomedical 
sensors where this signal of interest is physiological and clinically relevant information from 
the human body. 
In many cases, the human senses of the physician will suffice to gather the necessary 
information about the condition of the patient, for example when inspecting a wound. 
However, biomedical sensors provide a door into important information which is not 
accessible with the senses of either physician or patient. Some biomedical sensors simply just 
amplify the senses of the physician, such as the stethoscope which enables diagnostics of 
heart or lung function by the amplified sounds generated by these organs. Nevertheless, most 
biomedical sensors measure another physical property which is translated into the property of 
interest. As an example, the pulse-oxymeter measures absorbance of light emitted through the 
finger, but converts this optical property into a number which quite accurately represents the 
oxygen saturation in the blood. Table 1 gives a list of different physical properties which are 
translated into important biomedical parameters by biomedical sensor methods.  
Table 1. Examples of different physical properties which are translated to important 
biomedical parameters by biomedical sensor methods. 
Physical property Sensor method Biomedical parameter 
Pressure Doppler ultrasound Blood flow velocity 
Light Pulse oxymeter Blood oxygen saturation 
Temperature Thermodilution Cardiac output 
Electrical potential Electrocardiogram (ECG) Heart function 
Electrical impedance Electrical impedance tomography Lung function 
 
The device which converts the physical property into a signal which can be more easily 
handled and quantified (e.g. voltage) is called a transducer.The transducer represents the first 
line in the flow of information from the body to the output which displays the biomedical 
parameter of interest, e.g. a patient monitor. Without proper transducers, the measurement 
will be useless. Second in line is the instrumentation which controls the measurement. This 
part usually consists of electronic circuitry with one or more microchips which are 
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programmed to perform measurements. A poorly designed instrumentation part will reduce 
the accuracy of the measurement. The third line is the step which converts the measured 
signal into useful information for the physician. This process involves removing redundant 
information, enhancing the information of interest and estimating the biomedical parameter 
by mathematical operations. The processing may take place within the microchips of the 
instrument, in the software on the monitoring unit which receives data and displays the result, 
or as a separate post-processing tool for analysis of stored measurement. In its simplest form, 
this step only filters noise, amplifies the signal of interest and leaves the interpretation to the 
eye of a trained physician, such as in ECG monitoring. In more advanced sensor systems, 
large amounts of data are used to automatically suggest a decision for the physician, such as 
with malignant melanoma detection [Aberg et al 2011]. The development of signal processing 
algorithms is a very important part of biomedical sensor engineering, and much of the 
innovation today lies in this part as many measurement technologies are approaching their 
limit and microprosessor computing capabilities have increased vastly. The final parameter 
shown on the screen can never be more accurate than the accuracy of the parameter estimation 
algorithm, which can never be more accurate than what is provided by the instrumentation, 
which again can never be more accurate than what the transducer can pick up from the body. 
Thus, all the parts shown in figure 1 are critical to a biomedical sensor.  
 
Figure 1. Information flow from the body to the monitor provided by the biomedical sensor. 
Depending on definition, the biomedical sensor can either be regarded as the transducer, the 
transducer together with the instrumentation, or all three parts as in figure 1. In this work, we 
consider everything in between the body and the final parameter displayed on the screen as 
the biomedical sensor. The work in this thesis concerns developments within these three parts 
for biomedical sensors being based on the physical property of electrical impedance, which is 
briefly explained below: 
Electrical impedance means to which degree something opposes the flow of electrons or ions. 
In order to have an electrical current through an object, there needs to be an electrical 
potential difference (voltage) between two points. The impedance is found from this voltage 
divided by the current, and is a passive property of the object. This is different from electrical 
potentials which are generated by the object itself, which is an active property. When 
electrical impedance is measured in a biological material such as the human body, it is called 
bioimpedance, and represents the opposition to the flow of ions through the body, not 
electrons as in a copper wire. The transducers which connect the biosensor to the body, apply 
the electrical potential and facilitate the transfer between electronic and ionic current are 
called electrodes. In bioimpedance measurement, the same electrodes can also be used to pick 
up the current which can be measured in order to calculate the impedance. More advanced 
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solutions use different electrodes for voltage excitation and pick-up. For an electrical 
impedance measurement, the instrumentation governs both the generation of voltage between 
the electrodes and the measurement of the current passing between them. The signal 
processing of bioimpedance measurement depends on the biomedical parameter of interest, 
and the raw bioimpedance values are rarely of clinical interest. 
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2.0 GENERAL AIM 
 
The vision at the author’s workplace, the Department of Clinical and Biomedical Engineering, 
is development of technology for the benefit of the patient. This implies that the technology 
must have potential for clinical use, and also that the technology must work. The focus 
technology in this work is impedance-based biomedical sensors, and this means that the 
sensors must have clinical significance, and that the measurement of the biological parameter 
must be accurate. As outlined in the introduction, the electrodes, instrumentation and signal 
processing are critical to this accuracy. Hence, the general aim of this work was: 
Improvements in electrodes, instrumentation and signal processing for biomedical sensors 
based on electrical impedance.  
Within each of these biomedical sensor parts, the aims were: 
x Electrodes: Assess how different electrode types influence measurement, both for non-
invasive and invasive electrical impedance measurement.  
x Instrumentation: To develop instrumentation suitable for portable and long-term 
recording of skin admittance in patients.  
x Signal processing: To improve the estimation of biological parameters based on 
electrical impedance signals coming from skin, tissue metabolism and the whole body. 
These aims are further specified within their respective chapters.  
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3.0 INSTRUMENTATION 
 
3.1 Introduction to instrumentation for impedance measurement 
Electrical impedance is a material property which has two components – the resistive and the 
reactive part. Thus, mathematically the impedance (Z) is expressed as a complex number by 
the sum of the resistance (R) and the imaginary reactance (X): 
ܼ ൌ ܴ ൅ ݆ܺሺͳሻ 
When a known electrical current is applied to a material, the impedance is found by 
measuring the voltage between the electrodes and dividing this by the current. In many cases, 
applying a known voltage to the material and measuring the current between the electrodes is 
more practical. The signal (current) then becomes inversely proportional to the impedance. 
This quantity is called electrical admittance (Y), which is also expressed as a complex number 
with two components conductance (G) and susceptance (B):  
ܻ ൌ ͳܼ ൌ ܩ ൅ ݆ܤሺʹሻ 
Depending on which of these electrical properties that is most interesting for the type of 
sensor in question, the Z, Y, R, X, G, B or a combination of these is extracted from the 
measurement. The X and B are dependent on the frequency (ω) of the current which is applied 
through the material and can only be measured by alternating the direction of the current. B is 
proportional to this frequency and the electrical capacitance (C) of the material can be found 
from B/ω. Thus, the first basic part needed for impedance measurement is a generator which 
applies controlled alternating current (AC) or voltage through the electrodes and the material.  
The second most important part is the acquisition of the resulting voltage between the 
electrodes from the applied current, or the resulting current through the electrodes from the 
applied voltage, which is needed to calculate Z or Y, respectively. The voltage can be read 
directly by an analog-to-digital converter (ADC), but the current needs to be converted to 
voltage before the acquisition. In both cases, the instrument will acquire an AC voltage signal 
which in amplitude is proportional to the Z or Y.  
Because the conductive (R or G) and the capacitive (X or B) components represent different 
properties of the material, the decomposition of these from the Z or Y signal is a part of most 
impedance measurement instrumentation. The preferred method for this third basic part is 
called phase-sensitive rectification (PSR), which implies extraction of only the component of 
a signal which has the same phase (temporal shift) and frequency as a reference signal. A 
purely conductive material will not change the phase between the applied and response signal, 
but a purely capacitive material will shift the phase by a quarter of the AC cycle (90˚). Thus, 
the conductive part can be extracted by PSR with a 0˚ reference signal, while the capacitive 
part is extracted in the same way using a 90˚ reference signal.  
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This phase angle of the signal is often used directly as a parameter for interpreting impedance 
measurements. Further information about the material, and especially for biological materials, 
can be gained by measuring impedance at multiple frequencies. This requires more advanced 
instrumentation for current/voltage application and acquisition.  
For bioimpedance measurement where the instrument is connected to e.g. patients, additional 
steps must be taken for electrical safety of the equipment. 
In summary, there are three basic parts or functions needed for impedance measurement 
instrumentation:  
1. AC voltage or current generator 
2. Signal acquisition 
3. Phase-sensitive rectifier (PSR) 
3.2 Problems with instrumentation for impedance measurement 
An advantage with impedance measurement is that the instrument requires only electrical 
components, as the physical property of interest is electrical or ionic and no transducers other 
than electrodes are needed. With 21st century electronics, utilization of smart components 
enables miniaturized and cost-effective design. However, most available impedance analyzers 
are still large and expensive. Stationary equipment for research or industrial process-control 
should still be as accurate as possible with no compromise for size or cost, but for biomedical 
sensors, portability or wearability of the sensor is often a key requirement.  
3.3 Aims of the instrumentation work 
The aim of this work was to design and develop instrumentation which is suitable for portable 
and long-term recording of skin admittance in patients. This included the following 
requirements: 
x The instrument had to be small enough to fit into a pocket or carried attached to a belt. 
x The instrument had to be continuously operative for 24 h. 
x The instrument had to be able to record skin admittance at four skin sites 
simultaneously. 
x The instrument had to satisfy hospital requirements for electrical safety.  
3.4 Summary of the results on instrumentation work 
3.4.1 Embedded design 
An embedded design was created with emphasis on performing most of the measurement 
functions within a microcontroller (μC) (Paper II). Instead of using a dedicated component for 
voltage generation, a μC was used to generate a sine-wave voltage using a combination of a 
lookup-table, an internal pulse-with modulator (PWM), a voltage divider and a low-pass filter. 
Signal acquisition of the current through the measuring electrode was implemented by 
current-to-voltage conversion using an operational amplifier and sampling of the converted 
signal by an ADC. The PSR function was implemented by digital processing of the sampled 
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current signal within the μC. Figure 2 shows the component layout of the solution in a) and 
the μC measurement process in b). Compared to conventional instrumentation using analogue 
components for specific functions, this design reduces the number of components needed and 
thereby the size, current usage and cost of the sensor. The digital solution with software 
control also provides flexible configuration of measurement parameters such as the applied 
voltage amplitude and frequency.  
 
Figure 2. Overview of the embedded design for skin admittance measurement 
instrumentation. a) Component layout with current-to-voltage conversion (I-V) of the current 
picked up at M, a microcontroller with ADC, PWM and serial port (UART), and external 
voltage divider and low-pass filter for controlled voltage between the electrodes (E and M). b) 
principle of the measurement process run by the microcontroller, in which most of the 
measurement processes are run digitally in software © 2008 IEEE. 
3.4.2 Portable skin conductance sensor for clinical use 
Based on the embedded solution (Paper II), a portable device for multichannel skin 
conductance measurement was built (Paper I). 
In order to provide measurements which are sensitive to the skin rather than deeper tissue, the 
frequency of the applied voltage was carefully selected based on previous research by 
Martinsen et al [Martinsen et al 1999].  
To facilitate measurements at different skin sites simultaneously which are sensitive only to 
the conductance of the skin below each measuring electrode, a special electrode system was 
used based on the earlier work by Grimnes in 1983 [Grimnes 1983]. For a sensor system with 
four measurement channels, a total of six electrode terminals were used, in which one is for 
current injection, another for voltage feedback sensing, and the rest for the measuring 
electrodes. In this way, simultaneous recording of skin conductance every second at four 
different skin sites was obtained.   
For portability and to cover the aspects of electrical safety for clinical use, wireless transfer of 
data was implemented in addition to on-board storage of measurements. In this way, the 
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patient is not electrically connected to the main power supply, and can move around freely. In 
addition, safety resistors were added at each terminal in order to reduce current exposure if 
breakdown of electrical components should occur. Software was developed for realtime 
monitoring of measurements on a PC. A photograph of the instrument which was built and a 
screenshot from the PC software is presented in figure 3.  
Figure 3. The developed multichannel skin conductance sensor system. a) Photograph of the 
instrument box (size 157 x 95 x 33 mm) with cables, electrodes, and a wireless reception 
module for PC connection. b) Screenshot from the PC software of a skin conductance 
recording at four different skin sites.  
This sensor was named the Sudologger and is today CE-marked and marketed by BioGauge 
A/S.  
3.4.3 PC-based instrumentation 
In some cases, PC-based instrumentation is practical, especially for prototyping or 
demonstration of new instrumentation ideas. The PC together with a data-acquisition (DAQ) 
card then replaces the microcontroller, and a front-end of electronics between the electrodes 
and the DAQ-card completes the system. A PC-based skin conductance instrument was 
developed (Paper III), consisting of a laptop, a PCMCIA DAQ-Card (Type 6062E, National 
Instruments) and matchbox-size front-end electronics, shown in figure 4a. For the purpose of 
demonstrating tissue type discrimination by needle bioimpedance [Kalvøy 2009 and Paper V], 
a PC-based demonstrator was developed from the same components and similar front-end 
circuitry (figure 4b).  
a) b) 
  Instrumentation 
9 
 
 
Figure 4. PC-based instrumentation for skin conductance (a) and tissue impedance (b) 
measurement. 
3.5 Discussion of the instrumentation work 
The Sudologger, which was developed based on the presented instrumentation design, has 
enabled recording of the skin conductance parameter in situations which have previously been 
impractical. Within our hospital, recordings for research have been done during exercise, heat 
exposure in a sauna, and ten patients have worn the system ambulatory for 48h. Other 
research groups have used the Sudologger for research on treatment of excessive sweating, 
research on night sweats, stress research, psychological research, diabetes research and 
research in basal physiology. Chapter 6 covers the clinical applications of the sensor in detail.  
The development of the system which is presented in Paper I took place from 2005-2007. 
Since then, electronic components and modules for embedded instrumentation have become 
even smaller, smarter and with low power consumption, in line with the developments in 
smart-phones. With today’s technology, the sensor could be miniaturized into e.g. a matchbox 
size of the instrumentation box. In 2011, the EEPROM in the Sudologger was replaced by 
mico-SD card storage, and a special version with fMRI compatibility is in development.  
A future version will include a redesign of the electronics, miniaturization, better ergonomic 
design and the inclusion of an accelerometer for registration of physical activity. In 2010, 
Grimnes et al [Paper VIII] developed a method for measuring skin potential in addition to the 
skin conductance and skin susceptance, simultaneously at the same skin site. PC-based 
instrumentation similar to Paper III and figure 4 was built for this purpose (not published), 
and was used in Papers IX and X to investigate the benefit of this feature. Due to findings in 
favor of this method, it will be implemented in a future version of the Sudologger.  
The PC-based instrumentation solution for skin conductance was published (Paper III, 2010) 
with the intention that other engineers and researchers could easily put together skin 
conductance instrumentation using a PC with LabVIEW®, a DAQ-card and a few standard 
electrical components. However, to our knowledge no other group has yet used this solution.  
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The demonstrator for bioimpedance measurement tissue discrimination provided accurate 
tissue discrimination between muscle and fat in pilot studies on in vivo porcine models after 
calibration (not published).  
3.6 Conclusion on the instrumentation work 
Instrumentation for portable skin admittance measurement which fits into a pocket was 
developed. The device is operative for 24h, can measure at four skin sites simultaneously and 
satisfies the requirements for electrical safety and patient use.  
 
  Electrodes 
11 
 
4.0 ELECTRODES 
 
4.1 Introduction to electrodes for impedance measurement 
Electrodes are critical to any impedance-based biosensor, as they serve as the physical 
connection between the material and the instrumentation and facilitate the transfer between 
electronic and ionic conduction. This makes the electrode material very important, as different 
materials have different charge transfer properties. Any electrically conducting material can 
serve as an electrode, but the material properties can have large effects on the measurement.  
For human use, the measurement can either be non-invasive or invasive, depending on 
whether the electrode is attached to the surface of the skin, or if the electrode is placed within 
the body. For non-invasive bioimpedance measurements, standard ECG electrodes are usually 
very suitable as they contain an electrolyte (ion containing) gel layer below the metallic part 
of the electrode, which serves to enhance skin contact and charge transfer across the skin. 
This gel also helps reduce the impedance from the skin, which is often an unwanted effect in 
the measurement. For invasive biompedance measurements, small metallic electrodes are 
used i.e. pacemaker leads, where the biocompatibility and long-term stability of the electrode 
material is important [Shepard 2009]. A third use of electrodes and impedance measurement 
in biomedical sensors is the sensing of electrochemical reactions. Biomedical sensors may 
utilize the chemical reactions between biological molecules and a reagent sensor solution in 
which ions are formed upon reaction and the changes can be picked up by the impedance of 
the solution. Although the electrodes are not in direct contact with the tissue in this case, the 
electrode properties are important regarding sensitivity and stability of the measurement, 
especially because such sensors often need miniaturization for clinical use, and the 
concentration of biomolecules and thereby the changes in impedance may be very small. This 
type of electrode shares the same requirement as the invasive bioimpedance electrode 
regarding stability. Figure 5 gives an illustrative overview of these three electrode 
applications. 
 
Figure 5. Illustration of three different electrode applications. a) Skin surface electrode with 
an electrolyte gel layer for skin impedance measurement. b) Needle electrode for invasive 
bioimpedance measurement. The needle is insulated down to the tip. c) Electrodes for an 
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electrochemical biomedical sensor measuring the impedance of a reagent solution interacting 
with the tissue. The yellow glow indicates the interfaces between electronic and ionic 
conduction. 
The work on electrodes in this thesis is divided into two electrode categories: 
1. Gel-based skin surface electrodes for non-invasive bioimpedance 
measurement. 
2. Small (<1mm2) metallic electrodes for invasive bioimpedance or 
electrochemical biomedical sensors. 
4.2 Problems with electrodes for impedance measurement 
4.2.1 Gel-based electrodes 
Gel-based electrodes have the benefit that they reduce the skin impedance, which is very large 
compared to deeper tissue and often introduce an unwanted effect in the measurement. 
However, for measurements where the skin impedance itself is the interesting property, the 
electrode should not influence the skin impedance. The skin conductance parameter is 
frequently used within psychological research, and a certain type of gel-paste has been 
recommended as an electrode-gel. However, many different types of standard or custom-made 
gels are still being used for these sensors. Differences in these include electrolyte 
concentration, water sorption properties and viscosity. It has been unknown how differences 
in electrode gels affect the skin conductance measurement, as this has not been studied in 
detail before.  
4.2.2 Metallic electrodes 
Depending on the electrode and the material it is in contact with, there is an impedance of the 
interface between the electronic conduction in the electrode and the ionic conduction in the 
material. This impedance is called electrode polarization impedance (EPI) [Grimnes and 
martinsen 2008]. For the small metal-based electrodes, EPI may become relatively large 
compared to the tissue or electrochemical solution, which reduces the sensitivity of the 
measurement. As the electrode area decreases, the EPI increases, but depending on the surface 
structure of the electrode material, the effective electrode area may be manifold that of the 
geometrical area. Thus, the ideal electrode should have a rough surface structure rather than a 
flat, and the relation between surface structure and bioimpedance measurement has not been 
studied in detail before. Consequently, the first problem is sensitivity, and the second problem 
is stability. If the EPI is changing during the measurement, which can be over several days for 
such a sensor, the measurement will suffer from a drift which changes the baseline level over 
time. This can be due to reactions between the electrode material and the tissue or with the 
electrochemical solution. The two problems are connected, as a continuous increase in EPI 
will not only introduce a drift, but also gradually reduce the sensitivity of the measurement.  
The EPI is also dependent on the frequency of the current across the interface, and the EPI 
contribution may thus be reduced by increasing the measurement frequency. However, 
parasitic capacitances dominate the higher frequencies, especially for miniature sensors. Thus, 
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the optimal measurement frequency must generally be selected based on a compromise 
between these two effects [Mirtaheri et al 2004]. Another way to overcome the EPI is to use 
separate electrodes for current injection and voltage pick-up (4-electrode system), but this is 
more difficult to assemble in a miniature sensor [Mirtaheri et al 2004].  
4.3 Aims for the work on electrodes 
4.3.1 Gel-based electrodes 
For the gel electrodes, the aim was to compare different types of gels with respect to skin 
conductance measurement. This included: 
x Assessment of water sorption characteristics for different gel types. 
x Measurement of area-corrected gel electrolyte impedance. 
x Simultaneous recording of skin conductance (SC) at palmar and abdominal skin, using 
electrode pairs with different gel at bilaterally equal sites.  
x Comparison of stability, responsiveness to skin impedance changes and susceptibility 
to pressure-induced artifacts.  
x Assessment of skin impedance change and skin irritation from 24 h adhesion of the 
electrodes.  
4.3.2 Metallic electrodes 
For the metallic electrodes, the aim was to compare the EPI of electrodes from the same 
material, but with different surface properties. These properties were contact area, alloy 
composition, surface structure and electrolytic treatment of the electrode. This included: 
x Impedance frequency spectrum measurement of different stainless steel electrodes in 
vitro, repeated over 48h to gather data on stability.  
x Investigation of impedance stability with respect to contact area, alloy composition, 
surface structure and electrolytic treatment.  
x Determination of the optimal measurement frequency. 
  
Electrodes   
 
14 
 
4.4 Summary of the results on electrode work 
4.4.1 Gel-based electrodes 
Electrodes with the following gel types were investigated:  
Table 2. Overview of the electrode gel types examined in this study according to gel material, 
the intended use, effective electrode area (EEA) and type of adhesion. 
Type Gel material Intended use EEA [cm2] Adhesion 
A Solid hydrogel ECG, neonatal 5.05 Adhesive gel 
B Wet gel ECG, short-term 2.54 Outer adhesive part 
C Isotonic EDA jelly EDA 1.95 Outer adhesive part 
D Karaya solid gel ECG, hypoallergenic 6.16 Adhesive gel 
 
Water sorption characteristics of one sample from each gel was measured gravimetrically 
using a dynamic vapor sorption instrument (DVS). From these measurements, the relative 
water uptake from steps in 10% relative humidity (RH) was calculated along with the time-
constant of the weight change of the sample. Types B and C contained high amounts of water 
initially of approx. 6 and 4 times the 0% weight respectively, while types A and D were very 
similar with less than 10% water depleted to the environment. Types B and C did not regain 
their original water content even at 90% RH. No hysteresis was observed between increasing 
and decreasing RH steps, except for type B between 60% and 80% RH.  
Type B had the highest conductivity, followed by type C, A, and type D with lowest 
conductivity as shown in table 3. 
Table 3. Gel AC conductivity [μS/cm] at low and high frequencies for all the gel types 
presented as median (bold), 25% and 75% quartiles. 
Frequency                A                B               C                D 
1 Hz 166.0 (162.8, 174.4) 313.8 (301.3, 320.6) 282.0 (265.7, 290.5) 3.600 (3.299, 3.676) 
100 kHz 399.1 (390.3, 407.4) 1480 (1445, 1523) 670.6 (597.9, 737.1) 71.81 (70.58, 73.27) 
 
From SC recordings on 18 subjects, several significant differences in time-series parameters 
were found between the electrode types. Type B had significantly higher initial drift than type 
A, C and D at palmar skin, and significantly higher drift than type A and D at abdominal skin. 
Type B was significantly different from all the others with respect to responsiveness to skin 
impedance changes, which were induced by sweating. On palmar skin, the SC response was 
significantly higher in magnitude than for the other gels, which was also the case on 
abdominal skin, but with the response in the negative direction, which only occurred for type 
B. On palmar skin, the offset between SC at baseline and at 15 minutes after sweating was 
significantly larger for type B than the others. On abdominal skin, this offset was significantly 
larger for type B compared with type A and D, while the type C offset was also significantly 
larger than for type A. Applied pressure to the electrodes generated a significantly larger SC 
response for type B and C compared to type A on palmar skin, while the type B response was 
significantly larger than for type A and D on abdominal skin. The initial SC drift correlated 
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positively with the initial desorption measurement (R=0.988, p<0.05 for palmar skin and 
R=0.901, p<0.1 for abdominal skin). 
Figure 6 shows an example recording from both skin sites where SC has been measured with 
type A and B electrodes simultaneously. On both sites, type B introduced a drift which was 
not present for type A, and type B gives a negative SC response during sweating at abdominal 
skin. 
 
Figure 6. Example recordings using different electrode type A and B on the same subject on 
palmar skin in a) and abdominal skin in b). The hatched area indicates the interval of 
sweating by physical exercise. 
No clear results were found for the skin impedance change from 24h of adhesion, except for a 
reduction in the resistance of gel type D, and no signs of skin irritation were found by 
photographic evaluation by a dermatologist.  
4.4.2 Metallic electrodes 
Electrodes of the following types were investigated:  
Table 4. Electrodes of medical grade stainless steel (MGSS) used in the study. 
Type Name Company Length x Diam. Active area 
1 Disposable Monopolar 
needle electrode 
Medtronic Inc. 37 x 0.33 mm 0.3 mm2 
2 Disposable Monopolar 
needle electrode 
Medtronic Inc. 50 x 0.40 mm 0.3 mm2 
3 TECA Needles Disposable 
monopolar needle electrode 
VIASYS Healthcare 37 x 0.36 mm  0.28 mm2 
4 Pirouette, Disposable EMG 
Needle 
Technomed Europe 40 x 0.35 mm Not given 
(0.5 mm2) 
5 Stimuplex A B.Braun Melsungen AG 50 x 0.7 mm Not given 
(0.7 mm2) 
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For new and untreated electrodes, significant differences among all the types were found for 
the impedance at all frequencies except for the highest (0.56 and 1MHz). As shown in figure 
7, the impedance spectra for these electrodes showed a clear increase in the impedance as the 
frequency decreased below 100-200 kHz for types 1 and 2, and below 10-20 kHz for types 3,4 
and 5. Although types 1, 2 and 3 had similar electrode areas, differences in impedance at low 
frequencies were up to 3-fold.  
Based on scanning electron microscopy (SEM) analysis of the electrodes, an alloy 
composition with no more than roughly 1% differences between electrode types was found, 
and the relation between the composition and the electrode impedance was thus not further 
investigated.  
Based on electrolytic treatment by applying positive (anodic) or negative (cathodic) DC 
current through the electrodes, large differences in impedance was measured. Cathodic 
treatment lead to decreased impedance and drift for all electrode types, and the impedance of 
type 1 and 2 was also reduced by anodic treatment. Types 3 and 5 had only minor impedance 
changes from the electrolytic treatment.  
Regarding stability, repeated measurements over 48h in a physiological saline tank revealed 
that type 4 was the most stable with no significant drift in impedance. The impedance of types 
1,2 and 3 increased during all repeated measurements and ended at twice or higher after 48h.  
 
Figure 7.Mean impedance vs frequency for new, untreated needles, sorted by type. (From 
Paper V by Kalvøy et al) 
4.5 Discussion of the electrode work 
Different electrode properties strongly and significantly affect the sensitivity and the stability 
of the measurement for both the gel-based and the metallic electrodes. 
4.5.1 Gel-based electrodes 
The results show that the choice of electrode gel can severely affect the SC measurement due 
to the gel reacting with the skin, and that this effect is correlated to the amount of water which 
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the gel can release. Differences in initial drift, response amplitudes and their directions, 
recovery offset and susceptibility to pressure artifacts indicate that an inappropriate choice of 
electrodes could lead to implications with clinical decisions based on SC measurement. The 
findings are summarized as follows: 
x Electrode gels can introduce large changes in the level of skin conductance over time, 
corresponding with the amount of free water in the gel and its viscosity.  
x Sweating can lead to negative skin conductance responses for wet gels with low 
viscosity. This inverse sweating response effect probably depends on the thickness of 
the SC. 
x Wet gels may provide an increased sensitivity to sweat activity in partially filled ducts. 
x Solid gels have in general a better ability than the wetter gels to return the skin 
conductance to baseline during recovery after a period of sweating.  
x Wet gels seem to give less repeatable measurements due to the changes introduced by 
the gel which likely depend on the interindividual SC properties.  
x Expectedly, the gels with lower mechanical stability are more susceptible to pressure 
artifacts.  
x The karaya-based solid gel (Type D) may introduce a drift in the skin conductance 
measurement due to lowering of its initially high resistivity.  
x The Isotonic EDA Jelly (Type C) may be completely absorbed by the skin during 
long-term wear.  
Based on these findings, electrode type A is used for the measurements in following 
studies (Paper III, IX, X and XII).  
4.5.2 Metallic electrodes 
The increase in impedance as the frequency is decreased, as seen in figure 7, is due to the EPI. 
Thus, the optimal measuring frequency should be above 200kHz for types 1 and 2, and above 
20 kHz for types 3,4 and 5. Stray capacitances are however likely to influence the 
measurement at 200 kHz for sensors with small distances between the electrodes.  
From SEM images of the electrode surface, large variations in surface roughness were seen 
among electrode types. Although the shape of the type 3 surface was different from type 1 and 
2, the increased real surface area was not large enough to explain the large impedance 
differences. Both the geometrical area and the roughness was larger for type 4 compared to 
1,2 and 3, in agreement with the lower impedance of this electrode. Type 5 had the largest 
geometrical area, and also a large surface roughness factor, in agreement with the lowest 
impedance at lower frequencies.  
Although the variation in contact area and roughness of the electrode surface was in 
agreement with the variation in EPI among the electrodes, not all of the observations could be 
explained, suggesting that factors not included in this study have significant influence on the 
electrode properties. 
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The effect of treatment suggests that cathodic DC current generates processes at the electrode 
surface which reduces the EPI and the drift. Electrolytic pretreatment of electrodes could thus 
be a recommended procedure before impedance measurement.  
There was in general an agreement between lower EPI and increased stability. Differences in 
long-term stability among the electrode types suggests that electrodes for impedance 
measurement should not be picked randomly although the differences in given producer 
characteristics may seem negligible.  
4.6 Conclusion on the electrode work 
The properties of electrodes are critical both for non-invasive and invasive impedance-based 
biomedical sensors. Inappropriate electrode choice leads to drift, altered sensitivity or other 
artefacts in the measurement.  
For skin impedance or skin conductance measurement, solid hydrogel electrodes are 
recommended due to the least disturbance on the innate skin impedance.  
For impedance measurements using small metallic electrodes, more stable and sensitive 
measurements are obtained by electrodes with rougher surface area, by cathodic pretreatment, 
and by using higher frequencies for the impedance measurement.  
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5.0 SIGNAL PROCESSING 
 
5.1 Introduction to biomedical signal processing 
5.1.1 Scope 
There are two general rationales for performing signal processing: (1) for the acquisition and 
processing of signals to extract a priori desired information; and (2) for interpreting the nature 
of a physical process based either on observation of a signal or on observation of how the 
process alters the characteristics of a signal. [Bruce 2001]. The work in this thesis concerns 
both of these rationales. After a physical property has been converted to an electrical signal by 
a transducer and acquired by the instrumentation, the biological signal will often contain both 
desired and unwanted components. The first part deals with extraction of the desired 
components or removal of the unwanted components, which is called filtering. Unwanted 
signal components may either originate from the body, i.e. when the electrical activity of the 
heart disturbs the measurement of respiratory muscle activity, or in the instrumentation as 
electrical noise from the circuitry or from external fields i.e. the power supply. In both cases, 
knowledge of the nature of both the desired and unwanted signals will improve the filtering.  
Filtering can either be done in hardware using analogue components, or digitally in software. 
The phase-sensitive rectification (PSR) described in CH3.1 is a form of filtering, and was 
implemented digitally in the microcontroller of the skin admittance instrumentation. This is 
considered pre-processing in order to acquire the physical property (electrical admittance) 
which is being measured. The work in this part is limited to the mathematical processing of an 
acquired physical property into a biomedical parameter, in agreement with table 1 and figure 
1 in CH1.  
5.1.2 Examples 
In an ideal world, both the transducer and the instrumentation work perfectly, providing the 
sensor software with undistorted signals from the body. However, a number of factors such as 
transducer contact with the body, may distort the measurement although the physical property 
is correctly measured by the instrumentation. To give an example, given a wearable 
biomedical sensor which is used during physical activity, the transducer may occasionally 
lose contact with the body, creating outliers in the series of measurements. Calculating the 
mathematical median of a number of consecutive measurements can in this case give a better 
representation of the desired property, as the median is not affected by the magnitude of the 
outliers. This median filter can be implemented in the software of the microcontroller or 
monitoring unit for real-time processing of the signal, or in post-processing software for 
analysis of saved recordings. To elaborate further, the filtered signal may be used to estimate 
a biomedical parameter based on a known mathematical model for the relation between the 
physical property and the biomedical parameter. An example is a temperature sensor which 
uses the resistance of a temperature-dependent resistor (thermistor) to estimate the 
temperature by a known formula. For most accurate measurements, this formula needs 
calibration before use for adjustment to the individual transducer and the desired temperature 
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range. The functionality of the biomedical sensor may extend further with alarms being 
triggered if the measurement crosses a certain threshold. The biomedical sensor may go even 
further with reporting these measurements or alarms to a treatment device, creating a 
completely autonomous system which replaces the physician, such as with rate-responsive 
pacemakers which continuously tune the pacing signal according to sensor inputs of physical 
activity. 
5.1.3 Signals 
In order to correctly process the signal of a physical property into a biomedical parameter, it is 
important to know its source and signal characteristics. This work concerns signals of the 
following sources, physical properties and signal types: 
Table 5. Overview of the types of biomedical signals included in this work. 
Source Physical property Type of signal Biomedical parameter 
Skin Electrical conductance Time-series Sweat gland activity 
Skin Electrical potential Time-series Sweat gland activity 
Skin Electrical susceptance Time-series Skin moisture content 
Tissue (metabolism) Electrical conductance Time-series Tissue carbon dioxide 
Whole body Electrical impedance Spectrum Body composition 
 
The first four signals in table 5 are time-series, meaning that the physical property is 
measured successively in uniformly spaced time-intervals, and that the variation over time is 
of interest either for the signal processing, as with the median filter, or for the monitoring of 
the biomedical parameter. The electrical properties of skin are influenced by the skin moisture 
content and the sweat gland activity, and large variations occur within seconds as the sweat 
pores are filled with sweat [Paper I]. The skin susceptance is however not influenced by the 
sweat glands and is correlated to the skin moisture content [Paper V].  
The fourth signal in the table comes from a biomedical sensor for conductometric 
measurement of the partial pressure of carbon dioxide (pCO2), in which pCO2 increase is a 
marker of organ ischemia [Tønnessen 1997]. The sensor is based on a water-filled chamber 
enclosed by a semi-permeable membrane which allows diffusion of CO2 molecules into the 
water which dissolves into ions and thereby changes its conductivity. The conductivity is 
found by impedance measurement between two electrodes in the solution, as was outlined in 
CH4.1, and figure 5 c).  
The last signal in table 5 is not a time-series signal, but a spectrum of impedance 
measurements at different frequencies, such as figure 7, CH4.4. The bioimpedance spectrum 
measured over the whole body can be used to estimate the total body water, the extracellular / 
intracellular fluid balance, muscle mass and fat mass [Grimnes and Martinsen 2008].  
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5.2 Problems with impedance signals 
5.2.1 Electrical properties of skin 
It is known that the skin conductance (SC) and the skin potential (SP) are related to sweat 
gland activity [Boucsein 2012], and that the skin susceptance (SB) is related to the skin 
moisture content [Paper VII], but it is not known if these electrical properties can be used to 
estimate the amount of sweating, as water evaporated from the skin.  
Due to the link between sweat gland activity and the central nervous system (CNS) which 
regulates it, skin conductance (SC) or skin potential (SP) measurements are used to calculate 
parameters of CNS activity [Boucsein 2012]. A CNS burst to the sweat glands generates a SC 
response (SCR) and a SP response (SPR), and the frequency or the shape features of the 
responses are used to quantify the CNS activity. The SCR and SPR have similar shapes in 
some cases, but can also have very different shapes. This difference is not completely 
understood, as methods for comparing them have been lacking, but comprehensive theories 
have been proposed [Edelberg 1993].  
5.2.2 pCO2 measurement 
Long-term instability is a well-known problem for the conductometric pCO2 sensor [Varlan 
and Sansen 1997, Mirtaheri et al 2004a, 2004b], and also for pCO2 and pH sensors which are 
based on voltage (potentiometric) measurements [Zhao and Cai 1997, Gumbrell et al 1997, 
Mindt et al 1978, Drake and Treasure 1986]. Based on the findings in Paper V and work by 
others on electrode polarization impedance [Franks et al 2005], the electrodes are a likely 
source of this instability, which is observed as drift and sensitivity reduction over time for the 
pCO2 sensor. For clinical use, such a sensor should ideally be stable for 3 or more days. Until 
this issue is solved at the transducer part of the sensor (Figure 1, CH1), signal processing 
methods may offer an alternative solution to the problem. For the purpose of ischemia 
detection, an appropriate signal processing algorithm may provide early and accurate 
automatic detection despite the instability of the signal.  
5.2.3. Bioimpedance analysis 
As described in CH3.1, the PSR function of impedance sensor instrumentation derives the 
conductive and capacitive components from the impedance signal. These components can be 
used to calculate the phase angle of the impedance, which is often used in estimation of the 
biomedical parameter in bioimpedance measurements. However, not all commercial 
instruments have this function embedded, and they provide only the magnitude of the 
impedance. When an impedance spectrum is available, there are methods for estimating the 
phase angle based on the information inherent in the frequency dependency of the impedance 
magnitude. It is however unknown which of these methods produce the most accurate 
estimate. 
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5.3 Aims of the work on signal processing  
5.3.1 Electrical properties of skin 
In 2011, Grimnes et al introduced a method for measuring SC and SP simultaneously at the 
same skin site, and also presented recordings which showed that these two parameters are 
different in nature [Paper VIII]. Utilizing this method, the aims were to: 
x Determine how accurate the amount of sweating can be estimated based on 
simultaneous recordings of SC, SP and SB during variations in sweating. 
x Investigate the waveform difference between SCR and SPR in relation to sweating, 
skin hydration and other features of the electrical properties of skin, and to compare 
the findings with existing theories.  
5.3.2 pCO2 measurement 
The aim for the pCO2 sensor was to develop a real-time signal processing method for the 
earliest accurate detection of cardiac ischemia given the properties of the sensor, based on 
measurements from a porcine cardiac ischemia model.  
5.3.3 Bioimpedance analysis 
The aim on the bioimpedance signal processing part was to determine which of two methods, 
the Kramers-Kronig method and the Cole parameter method, provides the most accurate 
estimation of the phase angle parameter. 
5.4 Summary of the results on signal processing 
5.4.1 Electrical properties of skin 
PC-based instrumentation, similar to the system presented in Paper III, was built based on the 
method in Paper VIII in order to measure SC, SP and SB simultaneously at the same skin site. 
Using a QSweat® device as a reference for the amount of sweating, measurements were done 
on 40 healthy subjects during relaxation and mental stress. A multilinear regression model 
based on a combination of SC, SP and SB features was found by stepwise regression and 
model validation. The model estimated the sweating with an average error of 15.4%. Figure 8 
shows a plot of the measured vs estimated sweating. 
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Figure 8. Measured sweating vs estimated sweating based on SC, SP and SB. 
The same measurements were used to compare the SCR and SPR waveforms by the percent-
wise difference between their peaks, as shown in figure 9 as the SPRET. 
 
Figure 9. Illustration of the skin potential relative turning time (SPRET). The onset and peak 
of the SCR defines the 0% and 100% and the SPRET is found from the percent-wise difference 
from the SCR peak to the SPR peak. 
Roughly 30% of all SPRs were similar to the SCR (SPRET<10%), and the rest had SPRETs 
which were more evenly distributed towards 100%. Typical SPRs in different SPRET 
categories were constructed and presented. Within subject, the SPRET was found to correlate 
strongly with the slope and curvature of the increasing part of the SCR. Between subjects, 
SPRET was negatively correlated with the SB. As shown in figure 10, the median SPRET 
was positively correlated to mean sweat rate.  
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Figure 10. SPRET for all responses from all subjects vs time (above) for comparison with 
mean sweat rate (solid line below). The grey circles represent the median SPRET during each 
minute interval. The subjects were given arithmetic problems during minutes 5 to 7, 12 to 14 
and 19 to 21.   
Another important finding was that under periods of increasing sweating, the SPRs were 
easier to detect than the SCRs, as shown by example in figure 11.  
 
Figure 11. An example recording showing the SP (lower) yielding more detected peaks 
(circles) than for the SC (upper).  
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5.4.2 pCO2 measurement 
Based on a dataset of measurements from 17 sensors in tissue with induced ischemia by 
arterial occlusion, and 6 control sensors in non-ischemic tissue, an algorithm was developed 
for real-time drift correction. Figure 12 shows a comparison between the uncorrected and 
drift-corrected signals.  
The drift-correction led to earlier and more accurate detection of ischemia. Based on the drift-
corrected signal, ischemia could have been detected with 100% accuracy after 7 minutes of 
occlusion. The rate of change (the time-derivative mathematically) of the signal was also 
analyzed, which could provide earlier detection alone, but with lower specificity. Combining 
these two enabled a 96% accuracy of detecting occlusions lasting from 1 min to 15 min. 
 
Figure 12. Uncorrected signal from sensors in tissue exposed to ischemia (a) and non-
ischemic tissue (b), compared to drift-corrected signals from the same sensors in c) and d).  
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5.4.3 Bioimpedance analysis 
By comparing the estimated phase angles based on the two methods against the measured 
phase angle for 20 subjects, it was found that the Cole method was significantly more 
accurate for two of the investigated frequencies (50 kHz and 100 kHz), and that the two 
methods were not significantly different for 5 kHz and 200 kHz estimations (figure 13).  
Cole 5kHz
KK 5kHz
Cole 50kHz
KK 50kHz
Cole 100kHz
KK 100kHz
Cole 200kHz
KK 200kHz
P
ha
se
 a
ng
le
 a
bs
ol
ut
e 
di
ffe
re
nc
e
0,0
0,2
0,4
0,6
0,8
1,0
1,2
*
*
 
Figure 13. The absolute difference between estimated and measured phase angle using the 
Cole (grey) and Kramers-Kronig (white) approaches for four selected frequencies.  
5.5 Discussion of the results on signal processing 
5.5.1 Electrical properties of skin 
The results speak in favor of usefulness of the Grimnes method for simultaneous SC and SP 
measurement, whether it is for estimation of sweating, identification of CNS responses or 
basal research on the electrical properties of skin.  
A 15% error must be interpreted with regard to the intended application, but is nevertheless a 
significant improvement to estimation by the raw SC signal only (26% error). The most 
important parameter for the estimation was the sum of positive increments in the SC time-
series. For sensors with only SC measurements, an estimation with 18% error could be 
obtained by using this parameter only.  
Roughly 30% of the variation in sweating could not be explained by the electrical parameters, 
which suggests that factors such as the electrolyte concentration of sweat produce large 
variations which affect the electrical properties, but are not directly related to sweat 
production. 
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Interpretation of the SPRET and the factors which it was correlated to, in light of existing 
biophysical theories of the SCR and SPR, suggests that the SPRET itself represents the 
hydraulic capacity state of the sweat ducts. Although the SPRET was strongly correlated with 
several factors, these factors did not completely explain its variance, suggesting that this 
parameter may contain additional physiological information not accounted for by the 
investigated effects.  
The larger number of SP peaks than SC peak suggests that simultaneous recording of the two 
properties can improve the quantification of biomedical parameters for CNS activity.  
5.5.2 pCO2 measurement 
The detection accuracy indicates that the signal processing algorithm removed the unwanted 
component (drift) and preserved the desired signal (pCO2 changes). This is also supported by 
the measurements on the same animals using a different pCO2 sensor in Paper XIII, which 
shows flat curves between each occlusion (Figure 2). Although the data were not processed in 
real-time, the developed algorithm is suitable for real-time monitoring. However, this work 
has several limitations: 
1. The algorithm was developed in order to obtain the best possible early 
detection accuracy for a given dataset, and not evaluated on another 
independent dataset. Thus, the reported accuracy is a best-case result. (The 
number of measurements was too low to divide the dataset in two). 
2. The data came from recordings lasting only a few hours, which is vastly less 
than for the intended clinical use. 
3. The ischemia pig model which produced the data does not completely 
represent a real clinical setting, and real signals may include components 
which could be incorrectly filtered by the algorithm.  
Thus, the presented signal processing method is a start in correcting the errors which are not 
solved by improvements in the transducer technology.  
5.5.3 Bioimpedance analysis 
Although the Cole method produced the most accurate estimation, the results obtained are 
however good for both methods. The Cole method has the advantage that it requires 
measurements at only four frequencies (5, 50, 100 and 200 kHz), while the Kramers-Kronig 
method needs measurements up to at least 500 kHz.  
5.6 Conclusions from the signal processing work 
The following conclusions are drawn from the signal processing work: 
x The amount of sweating can be estimated from the skin electrical properties with 
acceptable accuracy (15% mean error) depending on the application.  
x The mechanisms of the electrical signals from the skin are now better explained. 
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x The Grimnes instrumentation for SC and SP measurement provides extended 
physiological information from the skin and CNS.  
x Sensor drift from electrode instability may be removed by signal processing methods. 
x The Cole Parameter approach is more accurate than the Kramers-Kronig approach for 
estimating the phase-angle from bioimpedance spectra.  
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6.0 CLINICAL APPLICATIONS 
 
6.1 Clinical use of impedance-based biomedical sensors as of 2012 
Sensor methods based on electrical impedance have been proposed for a wide range of 
clinical uses, covering most organs, tissue types and functions within the body, but few of 
these technologies have yet made it into routine clinical use. Table 6 lists some of those who 
have made it far in this respect as of 2012.   
Table 6. Some of the most successful impedance-based sensor methods with respect to clinical 
use as of 2012.  
Biomedical 
parameter 
Sensor method Invasiveness Status 
Lung ventilation 
distribution 
Electrical impedance 
tomography (EIT) 
Non-invasive On market for clinical use as the 
Pulmovista® 500 by Drӓger 
Medical GmbH. 
Cardiac output Impedance 
cardiography (ICG) 
Non-invasive Part of the Task Force® monitor 
by APC cardiovascular, on 
market for clinical use. 
Body 
composition 
Bioimpedance 
spectroscopy (BIS) 
Non-invasive On market for clinical use as the 
SFB7 by Impedimed. 
Cellular analysis Microelectrode array 
bioimpedance 
Cell culture 
sample 
On market for pre-clinical use as 
the xCELLigence system by 
Roche Diagnostics. 
Melanoma 
classification 
Skin BIS Minimally 
invasive 
Undergoing clinical trials, 
planned market release in 2012 
by SciBase AB. 
Fluid status Intrathoracic 
impedance by 
pacemaker 
Invasive On market for clinical use as a 
feature in St. Jude and 
Medtronic pacemakers. 
 
Although not used as sensors on their own, impedance measurement is also integrated in some 
clinical treatment devices such as electrosurgery equipment where vessel fusion feedback is 
given by the tissue impedance (Ligasure™) and in defibrillators where the shock delivery is 
adjusted based on chest impedance measurement (Philips HeartStart defibrillators). 
In addition, several promising impedance-based methods have potential for clinical use in the 
near future, such as multichannel intraluminal esophageal impedance for diagnosis of 
gastroesophageal reflux [Hernani et al 2011], microfiltrometer method for red blood cell 
deformability measurement [Amoussou-Guenou KM et al 2004], the dielectrophoresis 
method for cell characterization [Chung et al 2011] and non-invasive assessment of gastric 
motility by bioimpedance [Huerta-Franco 2012] to name a few.  
In general, impedance-based sensors have the advantage that the instrumentation is cheap, 
safe, and that measurements can be taken rapidly and often non-invasively, which are all 
attractive features for clinical use. However, although bioimpedance is a parameter which is 
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very sensitive to many properties within the body or in tissue samples, it is often limited by 
the specificity, in other words failing to discriminate between these properties, which brings 
the sensor below the accuracy requirements for introduction to the clinic.  
The papers in this thesis are related to different types of clinical applications, and the 
following chapters put the work in a clinical perspective by description of the related clinical 
problems and discussion of the potential for clinical applications based on the sensor methods.  
6.2 Sweating and hyperhidrosis 
6.2.1 Introduction to hyperhidrosis 
Hyperhidrosis is a disease causing excessive sweating, and was the original motivation for 
developing the portable skin conductance sensor. Hyperhidrosis has a prevalence of 2.8% in 
the US, and the patients often report very poor quality of life with occupational, emotional, 
psychological and physical impairment [Strutton et al 2004]. The cause of hyperhidrosis is not 
completely understood, although there are indications of elevated sympathetic nervous 
activity in patients with this disease [Iwase et al 1997]. The disease can be psychologically 
conditioned and a connection has been shown between anxiety and hyperhidrosis [Ramos et al 
2006a,b]. The most effective of the many different treatment options is sympathectomy, 
where the sympathetic nerve trunk in the chest is dissected. However, compensatory sweating 
where the patients report of increases in sweating at non-treated areas after receiving the 
procedure is extremely common [Ojimba and Cameron 2004]. One of the great challenges for 
the attending physician today is the lack of a useful method to quantitatively and objectively 
estimate the degree of sweating before and after treatment, and consequently there is no way 
to supply the subjective assessment of the patient when it comes to the degree of suffering and 
the result of treatment. Grading of sweating before treatment is exclusively based on the 
patient’s subjective evaluation, making it difficult to determine the indication for treatment 
and the treatment result. In addition to sympathectomy, there are other treatment options such 
as antiperspirants, iontosphoresis, drugs, botulinum toxin injection and surgical excision of 
sweat glands in the axilla. It is important that each patient receives the correct type of 
treatment corresponding to the severity of their symptoms and to avoid offering the more 
risky and costly procedures to patients with few objective symptoms [Kreyden et al 2002]. It 
is especially important to separate the patients with a real need for medical or surgical 
treatment from those who are better suited for a different approach. For palmar hyperhidrosis, 
little is known about the daily pattern of sweating [Krogstad et al 2006] and there is no 
consensus based on objective criteria as to when treatment should be given [Krogstad et al 
2004]. Iodine starch test, gravimetry, evaporation and skin conduction have all been proposed 
as objective estimates, but are limited to controlled laboratory research [Krogstad et al 2006]. 
Hence, there is a need for portable equipment for long-term measurement of sweat activity. 
6.2.2 The link between sweating and skin conductance 
There are several sources influencing the electrical properties of skin, but the sudomotor 
(movement of sweat) activity generates the largest changes in its electrical admittance. The 
skin has both conductive and capacitive properties, and as shown in figure 14a, sweating 
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mainly changes the conductive part of the admittance. A simplified electrical model for the 
electrical properties of skin is shown in figure 14b, where the resistors R1 and R2 represent 
the conductive pathway through the sweat duct, which changes in conductance as the duct is 
filled with sweat. It is thus R1+R2 which is of interest for measuring the sudomotor or sweat 
activity. A and B are terminals for the measuring and counter-electrodes respectively. R3 and 
C1 represents the epidermal admittance, while R6 represents the resistance from the deeper 
layers of the skin to the counter-electrode. R4 and R5 represents duct wall resistances at the 
epidermal and sub-epidermal levels, connected to biopotentials E2 and E1, where E1<E2. 
Due to C1, which increasingly admits current according to frequency, the sensitivity depth of 
the measurement also increases with the frequency of the signal used for measurement. Thus, 
a low excitation frequency yields a measurement sensitive to the epidermal skin properties, 
and especially the highly resistive corneum layer, while the contribution from R6 becomes 
negligible. A too low excitation frequency will however let the AC measurement signal fall 
within the frequency range of the skin biopotential activity, making it difficult or impossible 
to discriminate between the two. As shown in papers VIII, IX and X, these two signals are 
different, and a too low AC frequency or DC measurement would thus not correctly reflect 
the sweat activity. Hence, using an excitation frequency above the skin biopotential range 
while also keeping the C1 admittance low, e.g. 10 Hz, yields an admittance measurement 
sensitive to R1, R2, R3, R4, R5 and C1. Using the phase-sensitive rectifier technique, as 
described in CH3.1, cancels out the C1 contribution, leaving only the resistors. The 
resistances R3, R4 and R5 are either very large or constant compared to R1 and R2, making 
the temporal variation in the low-frequency skin AC conductance measurement selectively 
reflect the sudomotor activity. A great deal of this knowledge on electrical properties of skin 
comes from the many years of research in bioimpedance by S Grimnes and ØG Martinsen. 
 
Figure 14. Electrical properties of skin and sweating. a) skin conductance (G) and skin 
capacitance (Cp) during sweating induced by physical exercise (at 2h), from Grimnes (1984) 
by permission. b) An electrical equivalent model for the skin based on the Fowles model 
[Fowles 1974] and modified for AC measurement.   
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6.2.3 The potential for clinical use 
As presented in CH3 and in depth in Papers I and II, a portable skin conductance (SC) sensor 
(the Sudologger) was developed for clinical use. In paper I, the sensor was tested on 24 
healthy subjects who wore the system during relaxation and physical exercise. Shown by 
examples, the SC measurements were visibly correlated with periods of exercise, although no 
other reference parameter than heart rate was used in this study. In paper IX, the correlation to 
a reference method for quantitative sweating measurement was studied in detail, and a high 
within-subject correlation was found (median r=0.77). Recordings from 28 subjects are 
presented in figure 2, where the mean SC vs mean sweat rate correlated with r=0.94.  
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Figure 2. Mean time series of sweat rate (Swr), skin conductance (SC), skin potential (SP) 
and skin susceptance (SB) with 95% confidence intervals (dotted lines). The upper boxes 
indicates the intervals of relaxation and stress by arithmetics (hatched). 
The Sudologger was included as an objective measurement in a study on the treatment of 
axillary hyperhidrosis at Oslo University Hospital (Paper XII). The main purpose of the study 
was to compare the effect of two surgical techniques. Secondary goals were to evaluate the 
Sudologger method and to compare subjective scoring with objective measurements. The 
study was longitudinal, implying within-subject comparisons before and after treatment. 
Comparisons were also done between the types of treatment, but these observations were 
paired as each patient received one type of treatment at each armpit. The Sudologger 
measurements were also compared with a traditional measurement of weight absorption of 
filter papers attached to the armpits.  
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Figure 15. Sudologger (a) and gravimetric (b) scores before treatment and at 3 months, 6 
months and 12 months after treatment (gray=type A, white=type B). *p<0.05 **p<0.01 
***p<0.001 significantly lower than preop. 
As shown in figure 15, the Sudologger provided measurements which suggested a clear 
improvement in sweating after treatment, which was not as significant for the gravimetric 
method. A stronger correlation to subjective scores (Table 7) for the Sudologger than the 
gravimetric measurement suggests that the Sudologger measurements may have been more 
correct.  
Table 7. Spearman rho correlation matrix for Sudologger, gravimetry, visual analogue scale 
(VAS) scoring of sweating and life quality, and dermatological life quality index (DLQI). 
Spearman rho Gravimetry VAS 
sweating 
VAS life 
quality 
DLQI 
Sudologger 0.66** 0.54**  -0.12 0.60** 
Gravimetry   0.38**  -0.18 0.41** 
VAS sweating      -0.34** 0.52** 
VAS life quality        -0.44** 
Both the Sudologger and the gravimetric measurement, along with the subjective scores, 
agreed that treatment type A was significantly more effective than type B.  
The Sudologger had several advantages compared to the filter paper method: 
x Less uncertainties during measurement, such as the pressure against the armpit during 
filter paper attachment. 
x Time-series recording allowing registration of sweating reactions to different types of 
stimuli.  
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x The multichannel system allows simultaneous measurement at other control sites, such 
as the palm which was used in this study as a control for different degrees of 
nervousness from visit to visit (inclusion of this covariate produced the same result). 
A disadvantage was saturation of the measurement in a few cases of extreme sweating, but 
this was due to equipment calibration and is not a methodological limitation.  
The Sudologger is currently being used in a study on thoracoscopic sympathectomy treatment 
of palmar hyperhidrosis at Akershus University Hospital by E.Øvensen et al. While patients 
are still being recruited, the group presented preliminary results (46 patients) as a poster 
[Appendix] at the 9th international symposium on sympathetic surgery, Odense 2011. The 
multi-channel sweat activity recording of the Sudologger enabled quantitative assessment of 
both the intended treatment of the palmar hyperhidrosis and side-effects of compensatory 
sweating at other skin sites.  
In conclusion, these results suggest that the Sudologger is clinically useful for treatment 
evaluation of hyperhidrosis. Implementation of the estimation model presented in Paper IX 
will also allow for between-subjects comparisons, which can offer physicians assistance in 
diagnosis as well. Before clinical routine use, some aspects need further consideration: 
x For long-term (24h+) recording on hyperhidrosis patients, the electrode fixation needs 
improvement. It is unlikely that the electrode will keep stable contact with the skin 
over long periods for heavy sweaters.  
x The estimation accuracy needs to be validated also for repeated measurements under 
different conditions in order to determine its repeatability and reproducibility. 
x The device should be ergonomically improved for unobtrusiveness during wearable 
use. 
Although sweating-related diseases are not highly prioritized and the market potential of the 
sensor is not huge, the technology can help certain groups of patients in the long-term. An 
objective screening of patients for appropriate treatment selection can also be beneficial for 
the healthcare economy.  
6.3 Electrodermal activity and the sympathetic nervous system 
The previous chapter dealt with the SC with respect to the amount of sweating, but a SC 
recording can also be used to extract information about the activity in in the central nervous 
system (CNS). The sweat glands are innervated by the sympathetic branch of the CNS, and a 
nervous impulse to the sweat glands trigger a sudomotor response which can be picked up by 
a response in the SC signal [Kunimoto et al 1991]. Thus, counting the number of SC 
responses (SCRs) during a time window can give an estimate of the sympathetic nervous 
system (SNS) activity, or the reaction to a certain stimulus can be estimated by looking at the 
following SCR amplitude. The regulating mechanism of the SNS activity is complex, and it is 
difficult to determine the source or cause of the activity (see Boucsein 2012 CH 1.3.4 for 
details). These parameters are much used within the field of psychophysiology as indices of 
e.g. arousal or stress, where the measurement is known as electrodermal activity (EDA). 
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Within this field, EDA has been used in applications such as biofeedback, assessment of 
personality traits, psychopathology and detection of deception [Boucsein 2012 CH3], to name 
a few. EDA is not well established in clinical use, and is mostly used in research, often in 
combination with other physiological measurements. Recently, EDA has been used in 
research on epilepsy [Poh et al 2012], post-traumatic stress disorder [Fletcher et al 2011], 
sleep research [Michael 2011] and disabled patients [Kushki et al 2012] with promising 
potential for clinical applications.  
The Sudologger is directly usable for EDA measurement in a clinical setting. It is however 
not the only sensor available. In 2010, Poh et al presented what has become the Q-Sensor 
from the MiT Media Lab [Poh et al 2010, www.affectiva.com], which is superior in technical 
design to the current version of the Sudologger. It has an elegant design as a wristband with 
wireless communication for unobtrusive wearable use. There are however methodological 
differences in the way measurements are done, such as the electrical property measured, the 
site of measurement and the type of electrodes which may or may not be significant with 
respect to the intended use. These issues are not further discussed without research on the 
impact of these methodological differences. The rationales for the Sudologger methodology is 
given in this thesis, and the innovation lies in the measurement methodology. 
Figure 16 shows the result from Paper III where 17 volunteers were subjected to different 
levels of stress while EDA was measured using the Sudologger method and later compared 
with the subjective stress scoring.  
 
Figure 16. Means and standard deviations of the number of EDA responses (black) and the 
subjective scoring (grey) for the three epochs. *p<0.05. 
In addition to the development of the Sudologger, the work in this thesis has contributed to 
the field of EDA measurement by the following points: 
x Investigation of how different types of electrode gels influence the SC measurement 
(Paper IV) 
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x Contributed to a better understanding of the biophysical mechanism of EDA through 
basal research on different electrical properties of skin (Paper X).  
x Findings suggesting improved detection of EDRs by using the Grimnes measurement 
method (Paper X). 
x Sharing of a PC-based instrumentation solution for EDA measurement (Paper III).  
6.4 Organ ischemia 
6.4.1 Introduction 
Ischemia means inadequate blood supply to an organ or local area due to constriction or 
obstruction of arterial blood vessels leading to that area or venous blood vessels draining the 
respective area. Myocardial infarction, cerebral infarction and shock are examples, and 
ischemia is a major cause of death in the western world. Since ischemia is reversible in many 
cases, an early detection could lead to earlier treatment to save the organ as well as the 
patient’s life [Tønnessen 1997].  
6.4.2 The link between ischemia and pCO2 
The function of every organ is dependent on adequate blood supply, in particular the demand 
of oxygen for cellular metabolism. If blood supply is reduced, and the oxygen supply 
becomes lower than the demand, the cellular metabolic biochemistry changes in order to 
produce energy differently. An increase in the partial pressure of CO2 (pCO2) then occurs, 
explained by two mechanisms: First an initial rise due to flow stagnation and thereby impeded 
pCO2 removal by effluent venous blood and later a rise when cell metabolism shifts from 
aerobic to anaerobic state [Venkatesh and Morgan 2002, Wælgaard et al 2012]. In all tissues, 
CO2 is generated under anaerobic conditions as a result of bicarbonate buffering an increase 
of protons due to anaerobically produced lactic acid [Tønnessen 1997] and degradation of 
energy-rich phosphate compounds like adenosine-triphosphate and creatine-phosphate 
[Rosano et al 2008]. 
6.4.3 Biomedical sensor for early detection of organ ischemia 
The development of a biomedical sensor for early detection of organ ischemia started with the 
PhD work of Peyman Mirtaheri, supervised by Tor Inge Tønnessen, Sverre Grimnes and 
Ørjan G. Martinsen [Mirtaheri 2004]. This work led to the development of a miniaturized 
conductivity-based pCO2 sensor suitable for clinical monitoring, which is today called the 
IscAlert™ sensor, shown in figure 17 as of 2009. The work in this thesis (Papers VI, XIII and 
XIV) concerns the further development and pre-clinical testing of this sensor.  
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Figure 17. Picture of the IscAlert sensor, showing the sensor tip and wire. 
6.4.4 The potential for clinical use 
In paper VI, calibration and signal processing methods were developed in order to remove 
sensor drift and increase the detection accuracy of the sensor for cardiac ischemia. These 
methods were used on the same data in paper XIII by Pischke et al, where the diagnostic 
potential of pCO2 and the IscAlert sensor was evaluated with comparison to reference pCO2 
measurements, systemic haemodynamic parameters and regional metabolic parameters. An 
occlusion-reperfusion animal model for myocardial ischemia was used with sensors placed in 
the occluded area and a control area of the myocardium. As shown in figure 18a, pCO2 
measured by IscAlert sensors increased during each occlusion and was significantly different 
from the pCO2 measured in the control region. Figure 18b shows the reference pCO2 sensor 
measurements, which correlated well with the drift corrected IscAlert values (R=0.93 ± 0.05, 
p<0.001). The baselines are however different, as drift correction was not possible between 
sensor calibration and use, and the sensors were given a zero as baseline. This was however 
not important, as pCO2 increases were the hypothesized ischemic reaction, and the resulting 
detection accuracy was high (24%, 82%, 91% and 100% sensitivity for 1, 3, 5 and 15 min 
occlusions, all 100% specificity).  
Figure 18b also shows a new parameter which was calculated from the measurements: the 
time-derivative of the pCO2 curve (TDpCO2), representing the CO2 generation rate. This 
parameter was found to correlate strongly with the decrease in pO2, and reached is maximum 
as pO2 reached zero (anoxia). This suggested that this novel parameter may be important in 
determining the transition between aerobic to anaerobic metabolism.  
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Figure 18. pCO2 measurements during 1,3,5 and 15 minutes of induced ischemia by occlusion 
for IscAlert (a) and Neurotrend (b) sensors. In a) pCO2 in the occluded region (black line) is 
compared to pCO2 in a control region (grey line). In b) pCO2 and pO2 are compared to the 
TDpCO2. (See paper XIII for complete figure explanations). 
In comparison, no significant changes in systemic haemodynamic parameters were measured 
during ischemia. The ischemia was verified by regional metabolic parameters measured by 
microdialysis. It was concluded that the IscAlert sensors are applicable and enable immediate 
reliable recognition of ischaemic cardiac events. The main intended clinical application is for 
monitoring during and after cardiac surgery and especially coronary-artery bypass grafting.  
In paper XIV by Pischke et al, the IscAlert sensors were used in an animal model for liver 
transplantation. After liver transplantation procedures, it is important that the blood supply to 
the new liver is correctly established, and the aim of the study was to evaluate pCO2 as a real-
time diagnostic tool to detect occlusion of the hepatic artery (HA) or the portal vein (PV). 
Sensors were placed inside the liver in order to detect HA occlusion and between intestinal 
loops to detect PV occlusion. As shown in figure 19, HA occlusion caused significant liver 
pCO2 increase, and PV occlusion caused significant intestinal pCO2 increase. It was 
concluded that a combination of hepatic and intestinal pCO2 measurement reliably diagnoses 
the affected vessel, depicts the severity of the occlusion and emerges as a clinical monitoring 
tool in the per- and postoperative course of liver transplantation, enabling early intervention.  
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Figure 19. pCO2 increase detected by IscAlert sensors in liver during HA occlusion (A) and in 
intestine during PV occlusion (B). (See paper XIV for complete figure explanations).  
In conclusion, there is considerable potential for clinical use of the IscAlert sensor. There 
have already been many steps both in the medical basis and the technological development of 
the sensor, and there are still a few left before introduction to clinical trials. The work in this 
thesis has contributed to a few of these steps along the way, and some of the further steps on 
the technological side are discussed in CH 7.  
6.5 Needle guidance and tissue discrimination 
Paper V was part of a project for needle guidance in clinical applications based on electrical 
impedance, led by Håvard Kalvøy, PhD.  Briefly explained, Kalvøy et al found that the 
sensitivity zone of impedance measurement using a medical needle electrode is approx. 3mm 
in radius, which enabled tissue bioimpedance measurement with high spatial resolution 
[Kalvøy et al 2009]. 100% tissue discrimination accuracy was obtained in this study for 
porcine muscle and fat/subdermis data by multivariate analysis. The picture of the prototype 
in CH3.4.3, figure 4b gives an idea about the use of the sensor. Early suggestions for clinical 
applications were biopsies and ablation in small volumes, drug delivery transcutaneously into 
a vessel or a small volume of muscle, nerve or adipose tissue. The work in Paper V on needle 
impedance properties led to a better accuracy of the method based on needle type selection. 
Later, Martinsen et al described an application using the needle impedance method for blood 
vessel detection by invasive electrical impedance tomography [Martinsen et al 2010]. The 
intended clinical application was rapid localization of large blood vessels for resuscitation 
during cardiac arrest, and the preliminary results showed that blood vessel localization was 
feasible, according to the authors. The needle bioimpedance method also has potential for 
clinical use in delivery of epidural anesthesia, which is currently undergoing pilot studies for 
feasibility. 
In conclusion, this method has potential for several different clinical applications, but is still 
in its early stages and the focus application has not yet been determined.  
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6.6 Body composition analysis 
Paper XI by Nordbotten et al concerns the improvement of bioimpedance spectroscopy (BIS) 
signals from some existing devices intended to estimate body composition. This 
bioimpedance-based method is an existing technology available on the market and has already 
come very far with respect to a clinical application. As already shown in table 1, the 
technology is already available for clinical use. This method has a great potential, as it is the 
only technology available that has the potential to measure body water volumes (total body 
water (TBW), extracellular water (ECW) and intracellular water (ICW)) and body cell mass 
in the clinical setting, according to a 2007 review article by Earthman et al by 2007. The 
method is non-invasive and requires only placements of four skin surface electrodes on the 
hand/wrist and the foot/ankle. Specific clinical applications include outcome prediction of 
patients with lymphedema [Kim et al 2011], assessment of fluid status in hemodialysis 
patients [Dou et al 2012] and the diagnosis of metabolic syndrome [Ozhan et al 2012]. BIS 
can accurately measure TBW and ECW in healthy, normal-weight adults with normal fluid 
volumes and distribution [Earthman et al 2007], but the results are mixed in clinical 
populations, and the method was not recommended for routine assessment of patients until 
further validation, in a 2004 review by Kyle et al. As discussed thoroughly in a 2008 review 
article by Matthie, the method still has several technical issues regarding accuracy, which are 
related to the choice of measurement frequencies, current density, the skin impedance and the 
parameterization of the measurement. In other words: electrodes, instrumentation and signal 
processing. The work in this thesis contributed mainly on the parameterization of BIS, but the 
findings from the skin surface electrode study (Paper IV) is also relevant, as it shows which 
electrode gel type that most effectively reduces the skin impedance, which is a source of error 
in BIS. The instrumentation solution presented in Paper I may also be relevant, as reduced 
size and cost of devices is an expected development in this field [Matthie 2008]. 
6.7 Conclusion on the potential for clinical applications 
In conclusion, the work in this thesis has contributed both to the development of new clinical 
applications, and improvement of existing applications. The potential for each of these is 
dependent on many factors, such as the number of patients and clinical significance, the 
accuracy of the estimated biological parameter, the invasiveness of the measurement and the 
cost of the equipment. In order to give a very simplified overview, the applications are 
presented in a scatterplot of clinical significance and accuracy, shown in figure 20. The 
position and borders of each ellipse is based on the author’s impression of the accuracy, 
which also depends on the intended use, and the author’s impression of the clinical 
significance based on recent literature.  
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Figure 20. Clinical potential evaluated by the clinical significance and the accuracy of the 
applications (SL=Sudologger, NP=Needle Positioning, IA=IscAlert, EDA=Electrodermal 
Activity and BCA=Body Composition Analysis). Green represents technologies already 
available, while blue represents emerging technologies.  
In the coming years, these ellipses will narrow and their position will converge somewhere 
within their borders when the best possible accuracy is achieved and the application is 
completely specified. Whether or not the end-points cross a hypothetical line (red line in 
figure 20) will decide whether or not the application will be a success for clinical use.  
It is thus likely that the three new technologies will end up in routine clinical use. 
6.8 Disclosure 
A disclosure is relevant to this chapter, as the evaluations given beyond the referenced 
opinions reflect the view of the author only from his technological perspective. The author has 
earlier been financed by the company selling the Sudologger (BioGauge AS), and also the 
earlier company developing the IscAlert sensor (Alertis Medical ASA) for consulting work. 
The author has currently no interests in the discussed technologies other than scientific.  
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7.0 FUTURE WORK 
 
As the technology is not yet completely in the hands of the physicians, there is still work to be 
done. This chapter sums up the most important future directions for the different biomedical 
sensor projects related to the presented work. Suggestions are given for further investigations 
on electrodes, instrumentation and signal processing. Apart from the main goals of clinical 
applications, some ongoing work on basal research and new sensor ideas are also shared.  
7.1 Further work on electrodes 
x As textile, rubber, conductive polymer, and other new types of electrode materials are 
emerging for wearable sensor applications, these should also be assessed for skin 
impedance measurement with regard to long-term recording with the Sudologger.  
x Based on the results in Paper V, different electrode materials, and electrolytic 
treatments of them, must be studied with respect to impedance stability in 
experimental models specific for the IscAlert sensor. 
7.2 Further work on instrumentation 
x Due to the usefulness of the Grimnes method for simultaneous measurement of skin 
conductance, potential and susceptance, a microcontrolled-based design will be made 
for this method in an upcoming version of the Sudologger.  
x The practical difference in electrodermal activity measured by DC or AC methods 
needs to be determined by proper experimental comparison with a relevance to clinical 
use. 
x A special version of the Sudologger for use together with fMRI is under development. 
7.3 Further work in signal processing 
x The model for estimation of sweat production needs validation for repeatability and 
reproducibility under different conditions.  
x The mechanisms of electrodermal activity (EDA) is still not completely understood, 
and further investigations with the Grimnes method and the SPRET from paper X 
together with microneurography could shed light on the last parts of this puzzle and 
also improve the estimation of sympatethic nervous system activity by the EDA 
signals. 
x Ischemia detection algorithms for the IscAlert sensor need validation in clinical 
settings. 
7.4 Future outlook on clinical applications 
7.4.1 Hyperhidrosis 
A study on objective evaluation of botulinum toxin treatment of palmar hyperhidrosis is in the 
pipeline, in collaboration with the Department of Dermatology by Prof.Anne-Lene Krogstad.  
7.4.2 Night sweats 
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A group of researchers from the University of Oklahoma Health Sciences Center and Lynn 
Health Science Institute, Oklahoma, led by Dr. James Mold, are currently using the 
Sudologger in night sweats research.  
7.4.3 Post-traumatic stress disorder (PTSD) 
An fMRI-compatible version of the Sudologger is under development for research on PTSD 
in collaboration with Bjørn Christian Østberg, MD from the division of Mental Health and 
Addiction, Oslo University Hospital and the Institute of Psychiatry, King’s College London. 
So far, we have obtained undistorted recordings in the 1.5T MR, but not in the 3T MR.   
7.4.4 Diabetes: Sweating and unawareness of severe hypoglycaemia 
An idea for a potential application for the Sudologger originated from Prof. Trond Geir 
Jenssen at the Department of Nephrology, Oslo University Hospital. In treating diabetes 
patients, he had often heard reports of sweating during severe blood sugar falls, even in 
patients who had lost their normal prewarning senses of these blood sugar falls. In order to 
verify this physiological assumption and thereby the feasibility for early detection of severe 
hypoglycaemia (SH), a pilot study, funded by the Norwegian Diabetes Association and in 
collaboration with Marit Bjørgaas from St.Olavs Hospital in Trondheim, was initiated in 2011 
and will finish in 2012. The experimental part of 48h recording of 10 hospitalized patients is 
completed, and figure 21 shows a recording during one special episode in which the blood 
sugar of a patient dropped to dangerously low levels during sleep. In this example, the 
sweating reaction occurred 1h earlier than the critical point. Although the data analysis is not 
yet completed, several other incidents of low blood sugar coincided with increases in sweat 
activity.  
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Figure 21. Sweat activity at palmar (blue), forehead (green) and abdomen (red) skin sites and 
tissue glucose*10(black) during the night. The patient fell asleep at 22:30 and was awakened 
at 00:32 with cramps and impaired consciousness. *Blood glucose was measured to be 1.7 
mmol/l at 00:32. Strong sweat activity at the forehead started at 23:33. 
However, sweating can come from other causes as well, and expectedly, the specificity seems 
to be very low during the waking hours. We believe that this project is well worth pursuing, as 
it can enable early warning of very harmful events, and we are currently seeking funding for a 
3-year project. On the technical side of this project, a multisensor approach will be used to 
control for other causes of sweating by adding an accelerometer and temperature sensor. 
Further improvements in accuracy will be considered by inclusion of ECG parameters, 
continuous tissue bioimpedance and optical sensor methods.  
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8.0 GENERAL DISCUSSION AND CONCLUSION 
 
The general aim was improvements in electrodes, instrumentation and signal processing for 
biomedical sensors based on electrical impedance. In order to discuss the significance of this 
work with respect to improvements in these parts, the contribution to each are summarized as 
follows: 
8.1 Electrodes 
Electrode properties were found to be critical both for gel-based electrodes for skin 
impedance measurement and for metallic electrodes for invasive tissue impedance 
measurement. Errors from drift or altered sensitivity can be reduced or overcome by using a 
suitable electrode or by using electrolytic pretreatment and the optimal measuring frequency 
in the case of the metallic electrodes. Electrode properties affecting the measurement in 
general is not a novel finding, but the findings specific for these electrode types and how they 
influence the measurement in view of the intended impedance-based sensors are new and 
relevant to many applications. 
8.2 Instrumentation 
Instrumentation for portable skin admittance measurement was developed which fits into a 
pocket, is operative for 24h, can measure at four skin sites simultaneously and satisfies the 
requirements for electrical safety and patient use. To the author’s knowledge, this was the first 
portable (or wearable, depending on definition), device which could measure sweat activity at 
several skin sites simultaneously.  
8.3 Signal processing 
This work led to: Estimation of sweating amount by electrical properties of skin, a better 
explanation of the mechanisms of electrodermal actvity, a real-time sensor drift correction 
algorithm and a suggestion for parameterization of bioimpedance spectroscopy 
measurements. These are all new scientific contributions to the best of the Author’s 
knowledge, and could be useful for several clinical applications. 
Thus, the work has led to improvements in electrodes, instrumentation or signal processing 
for new or existing impedance-based biomedical sensors, thereby providing improvement of 
their accuracy and clinical potential. 
8.4 General conclusion 
This work has contributed to new biomedical sensors, and to knowledge which can lead to 
improvement of existing ones or in the way they are used. In light of the technical 
significance and the clinical potential discussed in CH6, the Author also concludes that this 
work is very likely to benefit the patient in the future.  
 
References  
 
46 
 
9.0 REFERENCES 
 
 
Aberg P, Birgersson U, Elsner P, Mohr P, Ollmar S. 2011 Electrical impedance spectroscopy 
and the diagnostic accuracy for malignant melanoma. Exp.Dermatol. 20:648-52. 
 
Amoussou-Guenou KM, Martinsen ØG, Hounkponou M, Doumit J and Healy JC 2004 Basic 
principles for evaluation of less deformable erythrocyte subpopulations with the 
Microfiltrometer. Scand J Clin Lab Invest. 64:169-74. 
 
Boucsein W. 2012. ELECTRODERMAL ACTIVITY, 2.ed. Springer New York. 
Bruce EN 2001 Biomedical Signal Processing and Signal Modeling. John Wiley & Sons. 
 
Chung C, Waterfall M, Pells S, Menachery A, Smith S and Pethig R 2011 Dielectrophoretic 
Characterisation of Mammalian Cells above 100 MHz. J Electr Bioimp 2:64-71. 
 
Dou Y, Zhu F, Kotanko P. 2012. Assessment of Extracellular Fluid Volume and Fluid Status 
in Hemodialysis Patients: Current Status and Technical Advances. Semin Dial  [Epub ahead 
of print] 
 
Drake H.F. Treasure T 1986 Continuous clinical monitoring with ion-selective electrodes A 
feasible or desirable objective? Intensive Care Med 12 104-107 
 
Earthman C, Traughber D, Dobratz J and Howell W 2007 Bioimpedance Spectroscopy for 
Clinical Assessment of Fluid Distribution and Body Cell Mass. Nutr Clin Pract. 22:389-405. 
 
Edelberg, R. 1993. Electrodermal mechanisms: A critique of the two-effector hypothesis and 
a proposed replacement. In Roy, J. C. et al. (Eds.) PROGRESS IN ELECTRODERMAL 
RESEARCH (pp 7-30). Plenum Press, New York. 
 
Fletcher RR, Tam S, Omojola O, Redemske R and Kwan J 2011 Wearable sensor platform 
and mobile application for use in cognitive behavioral therapy for drug addiction and PTSD. 
Conf Proc IEEE Eng Med Biol Soc 2011:1802-5. 
 
Fowles DC 1974 Mechanisms of electrodermal activity. In R.F. Thompson & M.M. Patterson 
(Eds.), Methods in physiological psychology (Bioelectric recording techniques, Part C: 
Receptor and effector processes, 1:231-71).New York:Academic. 
 
Franks W, Schenker I, Schmutz P, Hierlemann A 2005 Impedance characterization and 
modeling of electrodes for biomedical applications. IEEE Trans.Biomed.Eng. 52 1295-1302 
  References 
47 
 
Grimnes S 1983 Impedance measurement of individual skin surface electrodes. Med. Biol. 
Eng. Comput. 21:750-5.  
 
Grimnes S and Høgetveit JO 2011 Biomedical Sensors. Chapter in Handbook of research on 
Biomedical Engineering, Education and Advanced Bioengineering Learning. Abu-Faraj ZO 
(Ed). IGI Global. 
 
Grimnes S and Martinsen ØG 2008 Bioimpedance and Bioelectricity Basics (2nd.ed). Elsevier 
 
Gumbrell G P, Peura R A, Kun S and Dunn R M 1997 Development of a minimally invasive 
microvascular ischemia monitor: drift reduction results. Proc. 10th int.conf.IEEE/EMBS 
Oct.30-Nov.2 30 25-27 
 
Tolín Hernani M, Crespo Medina M, Luengo Herrero V, Martínez López C, Salcedo Posadas 
A, Alvarez Calatayud G, Morales Pérez JL, Sánchez Sánchez C 2011 Comparison between 
conventional ph measurement and multichannel intraluminal esophageal impedance in 
children with respiratory disorders. An Pediatr (Barc). [Epub ahead of print] 
 
Huerta-Franco MR, Vargas-Luna M, Montes-Frausto HB, Flores-Hernández C and Morales-
Mata I 2012 Electrical bioimpedance and other techniques for gastric emptying and motility 
evaluation. World J Gastrointest Pathophysiol. 3:10-18.  
 
Iwase S, Ikeda T, Kitazawa H, Hakusui S, Sugenoya J and Mano T 1997 Altered response in 
cutaneous sympathetic outflow to mental and thermal stimuli in primary palmoplantar 
hyperhidrosis J.Auton.Nerv.Syst.64 65-73. 
 
Kalvøy H 2010 Needle Guidance in Clinical Applications based on Electrical Impedance. 
PhD thesis, Faculty of Mathematics and Natural Sciences, University of Oslo 2010. 
 
Kalvøy H, Frich L, Grimnes S, Martinsen ØG, Hol PK and Stubhaug A. 2009 Impedance-
based tissue discrimination for needle guidance. Physiol Meas 30:129-40.  
 
Kim L, Jeon JY, Sung IY, Jeong SY, Do JH, Kim HJ. 2011. Prediction of treatment outcome 
with bioimpedance measurements in breast cancer relatedlymphedema patients. Ann Rehabil 
Med. 35:687-93. 
 
Kreyden O P 2002 Delusional hyperhidrosis as a risk for medical overtreatment: a case of 
botulinophilia Arch. Dermatol. 138:538-539. 
 
References  
 
48 
 
Krogstad A L, Mork C, Piechnik S K 2006 Daily pattern of sweating and response to stress 
and exercise in patients with palmar hyperhidrosis. British Journal of Dermatology 154:1118-
22. 
 
Krogstad A L, Skymne A, Pegenius G, Elam M, Wallin G 2004 Evaluation of objective 
methods to diagnose palmar hyperhidrosis and monitor effects of botulinum toxin treatment. 
Clinical Neuropysiology 115:1909-16. 
 
Kunimoto M, K Kirnö, M Elam and BG Wallin. Neuroeffector Characteristics of Sweat 
Glands in the Human Hand Activated by Regular Neural Stimuli. Journal of Physiology 
442:391-411, 1991. 
 
Kushki A, Andrews AJ, Power SD, King G, Chau T (2012) Classification of Activity 
Engagement in Individuals with Severe Physical Disabilities Using Signals of the Peripheral 
Nervous System. PLoS ONE 7(2): e30373. 
 
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, 
Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C. 2004. 
Bioelectrical impedance analysis – Part II: utilization in clinical practice. Clin Nutr 23:1226-
43. 
 
Martinsen ØG and Grimnes S 1999 Measuring depth depends on frequency in electrical skin 
impedance measurements. Skin res. techn. 5:179-181. 
 
Martinsen ØG, Kalvøy H, Grimnes S, Nordbotten B, Hol PH, Fosse E, Myklebust H and 
Becker LB 2010 Invasive electrical impedance tomography for blood vessel detection. Open 
Biomed Eng J. 2010; 4: 135–7. 
 
Matthie JR 2008. Bioimpedance measurements of human body composition: critical analysis 
and outlook. Expert Rev Med Devices 5:239-261.  
 
Michael L, Passmann S and Becker R 2011 Electrodermal lability as an indicator for 
subjective sleepiness during total sleep deprivation. J Sleep Res. [Epub ahead of print] 
 
Mindt W, Maurer H, Möller W 1978 Principle and characteristics of the ROCHE tissue pH 
electrode Archive of Gynecology and Obstetrics 226 9-16 
 
Mirtaheri P, Grimnes S, Martinsen ØG and Tønnessen TI 2004 A new biomedical sensor for 
measuring PCO2. Physiol.Meas.25:421-36. 
 
  References 
49 
 
Mirtaheri P, Omtveit T, Klotzbuecher T, Grimnes S, Martinsen Ø G, Tønnessen T I 2004 
Miniaturization of a biomedical gas sensor Physiol.Meas.25 1511-1522. 
 
Ojimba T A, Cameron A E P 2004 Drawbacks of endoscopic thoracic sympathectomy. British 
J. Surgery 91:264-69 
 
Ozhan H, Alemdar R, Caglar O, Ordu S, Kaya A, Albayrak S, Turker Y, Bulur S. 2012. 
Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome. J 
Investig Med. 60:587-91. 
 
Pallàs-Areny R and Webster JG 2001 Sensors and Signal Conditioning, 2nd.ed,Hoboken, NJ: 
John Wiley and Sons.  
 
Poh MZ, Loddenkemper T, Reinsberger C, Swenson NC, Goyal S, Sabtala MC, Madsen JR 
and Picard RW 2012 Convulsive seizure detection using a wrist-worn electrodermal activity 
and accelerometry biosensor. Epilepsia 53:93-97. 
 
Poh, MZ, NC Swenson, RW Picard. A Wearable Sensor for Unobtrusive, Long-term 
Assessment of Electrodermal Activity, IEEE Trans. Biomed. Eng. 57:1243-1252, 2010. 
 
Ramos R, Moya J, Morera R, Masuet C, Perna V, Macia I, Escobar I and Villalonga R 2006 
An assessment of anxiety in patients with primary hyperhidrosis before and after endoscopic 
thoracic sympathicolysis. Eur.Journ.Cardio-Thoracic Surgery. 30:228-31. 
 
Ramos R, Moya J, Turon V, Perez J, Villalonga R, Morera R, Perna V and Ferrer G. 2006 
Primary hyperhidrosis and anxiety: a prospective preoperative survey of 158 patients 
Arch.Bronconeumologia 2:88-92. 
 
Rosano GM, Fini M, Gaminti G and Barbaro G. 2008 Cardiac metabolism in myocardial 
ischemia. Curr Pharm Des. 14:2551-62. 
 
Shepard RK 2009 Leads and longevityy: how long will your pacemaker last? Europace 
11:142-143 
 
Strutton D R, Kowalski JW, Glaser D A and Stang P E 2004. US prevalence of hyperhidrosis 
and impact on individuals with axillary hyperhidrosis: results from a national survey J. Am. 
Acad. Dermatol. 241–8. 
 
Tronstad C 2005 Portabelt apparat for måling av svetteaktivitet. Master thesis, Norwegian 
University of Science and Technology, 2005. 
References  
 
50 
 
Tønnessen TI 1997 Biological basis for PCO2 as a detector of ischemia. Acta Anaesthesiol 
Scand, 41:659-69. 
 
Varlan A R and Sansen W 1997 Micromachined conductimetric p(CO2) sensor Sensors and 
Actuators B 55 309-15. 
Venkatesh B and Morgan TJ 2002 Monitoring tissue gas tensions in critical illness. Crit Care 
Resusc. 2002 4:291-300. 
 
Wælgaard L, Dahl BM, Kvarstein G, Tønnessen TI 2012 Tissue gas tensions and tissue 
metabolites for detection of organ hypoperfusion and ischemia. Acta Anaesthesiol Scand. 
2012 Feb;56(2):200-9 
 
Zhao P and Cai W.J 1997 An Improved Potentiometric pCO2 Microelectrode Anal.Chem. 69 
5052-5058. 
 
I

II
III

 
 
 
 
 
 
PC-based instrumentation for electrodermal activity 
measurement 
Christian Tronstad1, Sverre Grimnes1,2, Ørjan G. Martinsen2,1, Vegard 
Amundsen2 and Slawomir Wojniusz3,4 
1Department of Clinical and Biomedical Engineering, Oslo University Hospital, 
Rikshospitalet, Norway.  
2Department of Physics, University of Oslo, Rikshospitalet, Norway.  
3Department of Neuropsychiatry and Psychosomatic Medicine, Oslo University 
Hospital, Rikshospitalet, Norway.  
4Faculty of Health Sciences, Oslo University College, Norway 
E-mail: christian.tronstad@gmail.com 
Abstract. A PC-based EDA measuring system is presented. The system is composed of a 
laptop with a PCMCIA DAQ-card running LabVIEW® software, a small front-end with a dual 
op-amp IC and a few passive components, and three skin-surface electrodes. The electrode 
system gives a monopolar measurement below the measuring electrode regardless of the 
electrode sizes, unless very small. Usage of the system is demonstrated by measurements from 
a mental stress experiment on 17 volunteers. There was a significant correlation (R=0.51, 
p<0.001) between the self-assessed stress-level and the EDA response frequency. The system 
allows easy on-site customization in software of measuring parameters, signal-quality 
monitoring and non-linearity detection in real time. We believe that the most suited use for the 
system is for stationary experimental purposes where this flexibility is desired. The system is 
easy to reproduce by engineers interested in doing EDA research.  
1.  Introduction 
The activity from the sympathetic nervous system (SNS) regulates the secretory part of the sweat 
glands, which in turn changes the electrical properties of the skin due to the filling of electrolyte-
containing sweat in the ducts. These changes are mostly in the stratum corneum (SC) layer of the skin, 
and by measuring the SC conductance we can obtain a link to the SNS activity. This phenomenon is 
usually called electrodermal activity (EDA). The best sites for measuring EDA are known to be the 
palmar and plantar dermatomes, which probably differ from the innervation of sweat glands on the rest 
of the body [1]. There is a wide range of uses for EDA recordings, with applications within 
psychophysiology, ambulatory monitoring, intensive care and biofeedback among others.  
EDR instrumentation generally requires very few electronic components and can be built into small 
devices with low current consumption [2,3]. However, for stationary experimental purposes where a 
laptop is the monitor of choice, the instrumentation is easily realized by a DAQ card and a few off-the-
shelf components. This paper presents one such solution. EDA is known as an indicator of stress [1], 
and measurements from usage of the system in a mental stress experimental setting are presented.  
 
 
 
 
 
 
 
2.  Materials and methods 
2.1.  Instrumentation 
The measuring system is composed of three main parts, illustrated in figure 1:  
 
x Three skin surface gel electrodes. 
x Front-end electronics consisting of one dual op-amp IC, 5 resistors and two capacitors. 
x A laptop with a National Instruments 6062E DAQ-card and LabVIEW® software for signal 
processing, display and data storage.  
 
A low amplitude sine voltage generated by the D/A of the DAQ is applied to the skin through the E 
and R electrodes. Remote sensing at the current-less R electrode causes the right op-amp to drive a 
current through E which keeps the potential under R equal to the excitation sine, thus eliminating the 
SC impedance below E [4,5]. 
 
  
 
 
 
 
Figure 2. Photo of the system in use Figure 1. PC-based EDA 
instrumentation 
Because the impedance of the wet tissue is negligible compared to that of the SC, the only current-
opposing element that is left is the impedance of the SC below the M electrode. Thus, the 
measurement is monopolar regardless of the effective electrode areas (EEA) (unless very small [4]), 
and confined to the SC of the EEA below M. The major contributor to changes in this impedance is 
the filling and reabsorption of sweat in the sweat ducts. Measuring with AC eliminates the endogenous 
potentials generated by the skin or electrodes. The I-V dashed box on the left constitute a current to 
voltage converter with a Fc=200 Hz RC lowpass filter. The 100μ capacitor blocks DC which may 
saturate the op-amp and its impedance needs to be very small compared to the SC below M, thus the 
large capacitance. The 10k resistors are for safety in order to reduce the current through the skin 
should a breakdown in the op-amp occur. The digitized current signal is demodulated by the phase-
corrected excitation sine in software, giving the AC conductance G as the real part of the current 
divided by the excitation voltage. The voltage input and output of the DAQ is synchronized with the 
same sample clock. The op-amp power is supplied by the DAQ-card. Figure 2 shows a photo of the 
total system.  
 
2.2. Software 
Apart from the front-end with the op-amp IC as the only active component, all the measurement tasks 
are handled digitally in software. The digital lock-in technique is similar to that presented in [2]. For 
 
 
 
 
 
 
research purposes, the aim is to preserve as much as possible of the EDR signal information, because 
the EDR parameters may vary depending on the feature extraction methods when the sampling 
frequency Fs is decreased below a certain threshold. Very little signal energy is lost when Fs is as low 
as 1Hz, but depending on the signal feature extraction method, a higher Fs may be required. The 
requirement of using a low excitation frequency Fe for the EDA measurement [6] decides the 
compensation between Fs and the signal quality by means of the number of periods N for one 
measurement. The software will also need a certain processing time Tp between each measurement for 
signal processing, storage etc, giving the following limit for the maximum Fs: 
ܨݏ ൌ ൬ܰܨ݁ ൅ ܶ݌൰
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2.3. Experimental protocol 
17 volunteers (11M, 6F) who gave informed consent were subjected to three epochs of stress 
exposure, each lasting 10 min: Relaxation with classical music, quietly reading a text while provoked 
by irregular bursts of white noise and anticipation of public speaking while still receiving the white 
noise. The M electrode was placed on the hypothenar area of the palm, while the R and E electrodes 
were placed on the underarm, but the placement of these two is not critical. The skin AC conductance 
was sampled at Fs=8Hz.  
 
2.4. Data analysis 
As a measure of EDA response frequency, the number of EDA peaks (EDA TC) within a central five 
minute window within all the epochs was computationally determined by a top counting algorithm 
(A.1) and compared with a self-assessed stress score (1-10) of the volunteers using the Pearson 
product moment correlation. Comparison between the epochs was done using one way repeated 
measures ANOVA and the Holm-Sidak t-test. Normality was assumed based on the Shapiro-Wilk test.  
3.  Results 
The SNR of the conductance measurement was 74 dB with a phase error of 0.02º, tested in a lab with a 
high degree of electromagnetic interference. The linear dynamic range of the system with the 
configuration as in fig.1 was 0 to approx 200μS. This also depends on the type of op-amp used.  
There was a significant correlation between the EDA TC and the subjective stress-score (R=0.51, 
p<0.001). As shown in fig.3, both the EDA TC and the subjective score was significantly higher 
(p<0.05) during epoch 2 and 3 compared to epoch 1. Fig.4 shows an example measurement from 
epoch 2.  
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Figure 3. Mean and standard 
deviation of the EDA TC (black) 
and the subjective scoring (grey) for 
the three epochs. *p<0.05.  
Figure 4. Example measurement 
from epoch 2. 
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Discussion 
Expectedly, epoch 2 and 3 led to a higher self-assessed stress level than epoch 1. Although the 
protocol failed to produce a significant difference in mean stress level between the epoch 2 and 3, 
large intraindividual differences between these epochs were frequently observed. Thus, the correlation 
between the EDA parameter and the self-assessed score may be a better suited measure of the link 
between EDA and mental stress than the ANOVA. However, the variation in intersubjective 
understanding of the scoring will impact the correlation. Although the first 2.5 minutes of the epochs 
were excluded in the analysis to allow habituation to the noise, part of the EDA responses in epochs 
two and three may be directly caused by the acoustic stimulus, and whether this represents stress or 
not can be debated.   
    With this setup, measuring parameters such as the excitation voltage and frequency, phase 
correction, filtering and calibration is easily modified by a few mouse-clicks. In addition, the system 
enables automatic detection of artefacts or non-linearity from the raw input current signal, which can 
be important for this type of electrode system [4]. The simplicity of a laptop with only a cable, a front-
end box which can be made very small and electrodes as the total measuring system makes it 
convenient for use in an experimental setting where a laptop is the monitor of preference. This system 
would be easy to reproduce by biomedical engineers interested in doing EDA research and it would 
work just as well with most other types of DAQ-cards, e.g. the USB-DAQ which has become more 
popular lately.  
     For electrical safety, it is important to run the laptop on battery while measuring on live subjects in 
order to obtain a body floating connection with the equipment.  
 
Appendix 
With FFT analysis revealing negligible energy above 1 Hz, the window length was set to ͳܪݖ
the EDA TC was calculated as: 
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Abstract 
Skin conductance (SC) has previously been reported to correlate strongly with sweat rate 
(Swr) within subjects, but weakly between subjects. Using a new solution for simultaneous 
recording of skin conductance, skin susceptance (SB) and skin potential (SP) at the same skin 
site, the aim of this study was to assess how accurately sweat production can be estimated 
based on combining these electrical properties of skin. In 40 subjects, SC, SB, SP and Swr by 
skin water loss was measured during relaxation and mental stress. SC and Swr had high 
intraindividual correlations (median r=0.77). Stepwise multilinear regression with bootstrap 
validation lead to a sweating estimation model based on the sum of SC increases, the SP area 
under the curve and the SB area under the curve, yielding an interindividual accuracy of 
R2=0.73, rmse=12.9%, limits of agreement of +27.6%, -30.4% and an intraclass correlation 
coefficient of 0.84. Bootstrapping of training and test-sets gave median rmse=15.4%, median 
R2=0.66. The model was also validated for intraindividual variability. The results show that 
estimation of sweating is significantly improved by the addition of SB and SP measurement.  
 
Keywords: Sweating, sweat rate, skin conductance, skin potential, skin susceptance, 
bioimpedance, multilinear model 
 
Introduction 
It is well known that the in vivo electrical properties of skin are heavily influenced by 
sweating14. The outermost layer of the skin, the Stratum Corneum, provides a strong electrical 
barrier of dead skin cells when dry, but when sweat pores are filled with sweat, pathways of 
ionic transport are created which greatly reduces this electrical impedance through the skin. 
This provides a very sensitive measurement of sweat gland activity by means of the skin 
conductance (SC), and is widely used as a physiological parameter within many biomedical 
applications 3. Sweating also causes changes in the bioelectric potential (SP) at the skin 
surface, but the characteristics of this parameter is different from SC. While the SC always 
increases with the sweat duct filling and recovers while sweat is reabsorbed and/or pores are 
closed, the SP can change in both positive and negative voltage directions and produce 
biphasic or triphasic responses 3. A third electrical parameter to consider is the skin 
capacitance, which is positively correlated with the moisture content of the stratum 
corneum19, and is most accurately measured by low-frequency skin susceptance (SB)18. 
Although sweating, here defined as the amount of water loss from the skin by evaporation, 
and changes in the skin electrical properties both originate from the sweat gland, they are 
governed by completely different biophysical mechanisms. Sweating includes transport of 
sweat to the skin surface, evaporation and further transport of water molecules to the air. 
Some of the sweat is also absorbed in the skin and later evaporates at a decreasing rate, 
making the evaporation also dependent on the skin sorption characteristics. SC also increases 
as sweat fills the pores, but this is not necessarily dependent on sweat reaching the skin 
surface 10. After sweat pore filling, the SC decreases as electrolytes are reabsorbed through 
the sweat duct wall. The same mechanisms govern the SP response although the waveform is 
more complex10. Despite these biophysical differences, mainly the movement of water vs the 
movement of electrolytes, high within-subject correlations have been reported between SC 
and skin water loss (up to r=0.8821, r>0.858) and between the positive SP response and water 
loss (r=0.9312). Between-subjects correlations on the other hand, is reported to be lower than 
r<0.50 as a rule8 and between r=0.23 to 0.6421, suggesting one or more individual factors in 
the relation between electrical and evaporative skin properties. These factors could be 
differences in sweat electrolyte concentration17, thickness of the stratum corneum11 or the skin 
sorption characteristics. The SB parameter could approach some of this interindividual 
variance, as SB is not directly affected by sweat pore filling and reflects only the stratum 
corneum moisture content 18. Recently, a method for measuring SC, SP and SB at the same 
skin site was introduced by Grimnes15, enabling a new look on the relation between sweating 
and electrical properties of skin by inclusion of more parameters.  
The aim of this study was to assess how accurately sweat production can be estimated based 
on combining these three electrical properties of skin. This was implemented by the following 
list: 
1. Measure sweat rate (Swr) and the electrical properties SC, SB and SP during 
variations in sweating within and between subjects.  
2. Analyze individual temporal correlations between changes in Swr and electrical 
properties. 
3. Investigate between-subjects correlations between sweating and electrical parameters. 
4. Develop a model for estimating sweat production based on significant parameters. 
5. Validate the model for both between-subjects and within-subject variance. 
 
Materials and methods 
Skin admittance and potential measurement 
Based on the solution described in Grimnes et al 2011, a PC-based EDA measuring system 
for simultaneous recording of skin complex admittance (SY) and SP at the same electrode 
was developed, consisting of front-end electronics connected via a National Instruments® 
DAQ-card to a laptop running software written in LabVIEW® v8.5, similar to the 
instrumentation presented in Tronstad et al 201028. Instead of a saline bath immersion of the 
underarm as a reference electrode, a novel three-electrode system was used which ensures 
unipolar recording of SC regardless of electrode areas, thus allowing the use of the same 
electrode type at all sites. The constant current control was replaced by a Howland current 
source giving a 10 Hz AC current of 14μA to the skin. In addition to SC and SP 
measurements, the quadrature component of the SY signal was used to aquire SB. The 
differential amplifier was replaced by voltage sensing by analog-to-digital conversion at both 
terminals with software differencing, enabling control of the electrodermal inactivity at the 
reference site, which is a requirement for accurate SP recording3. Although abrasion9 or skin 
drilling30 is a recommended pretreatment for the inactive site, no pretreatment of the skin was 
used in this study to avoid risk of contamination and the need for associated procedures. The 
measuring electrode was attached at the hypothenar site of the palm, the SP reference 
electrode was attached to the apex of the elbow and a current sink electrode was placed on the 
underarm. The electrode type used was Arbo® Kittycat™, according to recommendations in 
Tronstad et al 201029.  
 
Sweat rate measurement 
Sweat rate (Swr) was measured by using the Q-sweat (WR Medical Electronics Co, 
Stillwater, USA).  The Q-Sweat uses dry air (room air, drawn across a desiccant) to pick up 
moisture from a measurement capsule (5.06 cm2 circular measurement area) placed on the 
skin. Constant airflow (60 cm3/min) through the capsule transports the captured moisture to 
the temperature and humidity sensors in the device. The airflow back and forth from the 
capsule to the Q-sweat passes through two 2.4 m air hoses.  
The skin capsule was attached on the hypothenar eminence of a randomly picked hand on 
each test subject (the opposite of the bioelectrical electrode).  This was done by first attaching 
the end of the silicone band to the capsule and turn the silicone band around the wrist and 
back over mounting spikes on the capsule. Then the remaining half of the silicone band was 
turned around the palm distal to the thumb and back to the capsule, where the end of the band 
was attached to the mounting spikes. This way the silicone band formed a figure of eight with 
the middle cross attached to the capsule. One of the circles forming the figure of eight was 
wrapped around the wrist, similar to a wrist band. The other half was the silicone band on the 
meta carpus, passing to the dorsal side of the hand distal to the thumb. The capsule position 
was adjusted by varying the tension in the silicone band in the four directions of the cross 
covering the capsule. This was done to even out the pressure between the capsule and the skin 
around the capsule, until a thigh fit was obtained and no leakage could be detected by the Q-
sweat software (WR-TestWorks 2.0.1). To further prevent air leakage, the test subject was 
asked to find a comfortable position for the hand and move it as little as possible during the 
measurements.  
A step-response test of the QSweat system was done before the experiments started to test its 
responsiveness. By sliding a probe from a dry to a wet surface, a response delay of 8s and a 
time-constant of 19.2s was found.  
 
Experimental protocol 
40 healthy volunteers (31 male, 9 female, age 17-64), were recruited from Oslo University 
Hospital and University of Oslo and gave informed consent before participation. The study 
was approved by the regional ethics committee (REK #2010/1927a).  
The experiments were done in silent laboratory or meeting rooms with only the test subject 
and two operators present. Room temperature was 22.5±1˚C. After bilateral fixation of EDA 
and QSweat sensors to the hypothenar area on both palms, the Swr measurement was 
monitored until stable levels were attained. The experiment was aborted if the Swr stabilized 
above the maximum of the QSweat measuring range (1000nL/min). At least 5 minutes were 
allowed for stabilization of EDA electrodes before the recording started. In order to produce 
variations in sweating and thereby duct filling over time, intervals of relaxation and mental 
stress were alternated. The subjects were sitting comfortably in a chair and were not allowed 
to speak with the operators. Mental stress was induced by asking the subject to repeatedly 
subtract seven from a starting number of 1000. This was repeated in three two-minute 
intervals, with 5 minutes for relaxation before and after, giving a total recording session of 26 
minutes.  
 
Data analysis and statistics 
Signal conditioning 
Due to noisy QSweat recordings, the time-series were low-pass filtered with a third-order 
zero-phase Butterworth filter with a 0.025 Hz cutoff frequency in order to dampen all noisy 
fluctuations sufficiently. The response delay and time-constant found from the step-test was 
used to correct the phase of the signal and the responsiveness by backwards-filtering through 
an inverted RC-filter with the measured time-constant.  
The Swr recording with a sampling frequency of Fs=4Hz were aligned with the EDA 
recordings with Fs=10 Hz by resampling to 10Hz by linear interpolation using the time-series 
tools in Matlab.  
 
Intraindividual time-series analysis 
To assess the synchronicity between the SC and Swr recordings, the cross-covariance matrix 
between the two signals was calculated for each subject and the relative time-shift at the 
maximum was used to estimate the lag between each signal pair.  A one-sample t-test was 
used to evaluate the significance of the lag.  
Based on an insignificant lag, the correlation between the SC and Sw time-series were 
evaluated by the Pearson product-moment correlation coefficient.  
12 Swr recordings which either saturated the measurement range (>1000 nL/min) or produced 
no increase above the measuring noise (5% threshold of 50 nL/min) during the stress 
provocation were excluded from the time-series correlation analysis.  
 
Interindividual correlations 
Similar to the time-series analysis, the recordings which saturated the Swr measurement range 
were excluded, but those with low responses (<50 nL/min) were included, giving a total of 33 
subjects used in this analysis. 
Total sweating (Sw) in μL/5 cm2 for each subject was calculated by the area under the curve 
(AUC) of the Swr recording for the whole duration of the session and was used as a 
dependent variable in a multilinear regression with EDA parameters as independent variables. 
Table 1 gives a complete list of all the variables used in the analysis.  
The NSCR parameter was calculated from a peak recognition algorithm using Matlab® where 
a peak at time t was recognized if there was 0.5s or more of continuous increase above 0.01 
μS on the left side and a decrease or flat 0.5s to the right side of t.  
The correlation between each pair of variables was determined by the Pearson product-
moment correlation coefficient. 
 
Table 1. Overview of all parameters extracted from the recordings and used in the statistical 
analyses.  
Parameter Description Function Unit 
Swr Sweat rate Dependent variable nL/min 
SC Skin conductance Intraindividual covariate μS 
Sw Sweating (Swr area under curve) Dependent variable μL 
AUC SC SC area under curve Interindividual covariate μSmin 
AUC SB SB area under curve Interindividual covariate μSmin 
AUC SP SP area under curve Interindividual covariate mVmin 
NSCR Number of SC responses Interindividual covariate dimensionless 
SCpos Sum of positive SC responses Interindividual covariate μS 
SPpos Sum of positive SP responses Interindividual covariate mV 
SPneg Sum of negative SP responses Interindividual covariate mV 
 
 
Model development 
In order to sift out reduntant independent variables and avoid overfitting,  stepwise regression 
was first used to find the best explanatory model. The stepwise regression method adds or 
removes terms from a multilinear model based on their statistical significance in a regression. 
Beginning with no terms, one independent variable was added at a time based on the lowest p-
value of its coefficients being zero if added to the model, until the model could no longer be 
improved by including more terms within the significance level (p<0.05). 
In order to validate the model suggested by the stepwise regression procedure, the model from 
each step was evaluated by bootstrapping. Random permutations were used to assign half of 
the dataset to a training set and the other half to a test set. The regression coefficients were 
then found from the training set and applied on the test set to calculate the root mean square 
error (rmse) of the estimation. This was also done on the model with all parameters for 
comparison. Distributions of the rmse for each model from 1000 bootstrap iterations were 
compared by a Kruskal-Wallis one way ANOVA on Ranks with Tukey post-hoc pairwise 
multiple comparison tests. The final model was selected based on the fewest number of terms 
and an rmse not significantly higher than any other model. 
 
Model validation 
Agreement between the model and the Sw was presented as a scatterplot using the mean 
coefficients from the bootstrapping, together with the coefficient of determination, R2, the 
Pearson product-moment correlation coefficient, r, the rmse and percent-wise rmse. A Bland-
Altman plot was constructed from the mean and differences between the measured and 
estimated sweating, with 1.96 std.dev limits of agreement. Reliability was assessed by the 
two-way mixed intraclass correlation coefficient for absolute agreement (ICC).  
In order to test the validity of the model upon intraindividual variability, estimation was 
assessed both during periods of high and low sweating according to the ends of the stress and 
relaxation intervals. Sw and all model parameters were extracted from the last minutes of all 
stress periods for the high sweating dataset, and during the last minutes for all relaxation 
periods, except the last, for the low sweating dataset. Sweating was estimated from the same 
mean coefficients from the total dataset. The two estimations were compared by their linear 
regression trend-lines from scatterplots between measured and estimated sweating within the 
same graph.  
All data-analysis was done using Matlab R2011 a, Sigmaplot 11.0 and SPSS 19.  
 
Results 
Intraindividual time-series analysis 
Based on the cross-covariance, the SC and Swr signal was highly synchronized, with an 
insignificant (p=0.19, One-Sample t-test against zero) lag of the Swr with median 1.05s, 25% 
percentile -3.6s and 75% percentile of 12.05 s.  
The temporal correlation between the SC and Swr time-series was median 0.77 (p<0.001), 25 
% percentile 0.67 and 75 % percentile 0.84. The correlation between the means of SC and 
Swr was 0.94 (p<0.001).  
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Figure 1. Mean time series of sweat rate (Swr), skin conductance (SC), skin potential (SP) and 
skin susceptance (SB) with 95% confidence intervals (dotted lines). The upper boxes indicates 
the intervals of relaxation and stress by arithmetics (hatched). 
 
 
Figure 2. Histogram of intraindividual correlation coefficients between Swr and SC (N=28).  
 
Interindividual correlations 
Pearson product-moment correlation coefficients for all interindividual parameters are 
presented in table 2 (N=40). Sw correlated strongest with SCpos (r=0.76) and NSCR (r=0.65), 
and these two parameters were strongly correlated to each other (r=0.77). 
 
Table 2. Pearson product moment correlation coefficients between all interindividual 
parameters. 
Pearson’s 
r 
AUC SC AUC SB AUC SP NSCR SCpos SPpos SPneg 
Sw 0.49** 0.39* 0.29 0.65*** 0.76*** 0.43** 0.17 
AUC SC  0.48** 0.02 0.79*** 0.66*** 0.02 0.014 
AUC SB   0.13 0.23 0.22 0.11 0.35* 
AUC SP    -0.08 0.19 0.28 -0.02 
NSCR     0.77*** 0.2 0.12 
SCpos      0.55*** -0.17 
SPpos       -0.21 
*p<0.05 **p<0.01 ***p<0.001 
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Model development 
Multilinear regression using all parameters gave an R2=0.84, r=0.91, rmse=1.7 μL. The 
stepwise regression lead to a model including the significant terms of SCpos, AUC SP, AUC 
SB and AUC SC in the given order (R2=0.82, r=0.90, rmse=1.7 μL). Validation of this model 
by bootstrapping lead to rmse distributions as shown in figure 3. Based on the ANOVA with 
pairwise comparisons, each step lead to a significant model improvement except for the last 
step with the inclusion of AUC SC, which significantly increased the rmse. Thus, the 
SCpos+AUC SP+AUC SB model was chosen for further assessment. 
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Figure 3. Distributions of rmse from 1000 bootstrap validation of models from the stepwise 
regression and the model including all terms. All distributions were significantly different 
except for model number two and four (p<0.05, Tukey Test for pairwise multiple 
comparison). Circles represent 5% and 95% percentiles.  
 
 
Model validation 
Table 2 also shows that none of the selected terms were significantly correlated (italic 
numbers). A scatterplot and a Bland-Altman plot of this model using the mean coefficients 
from the bootstrapping is presented in figure 4. The model estimated the measured sweating 
with an R2=0.73, r=0.85 and rmse=1.9 μL, which equals 12.9% of the measurement range. 
The limits of agreement was 27.6% above and 30.4% below the mean, which was close to 
zero due to the use of averaged coefficients. The reliability test of measured vs estimated 
sweating gave an ICC of 0.84.  
 
 
Figure 4. Scatterplot of measured vs estimated sweating based on the selected model 
(SCpos+AUC SP+AUC SB) with R2=0.73, r=0.85, rmse=1.9 μL (left) and Bland-Altman plot 
(right) showing the mean of the measured and estimated sweating vs their percent-wise 
difference. The solid line represents the mean percentwise difference (-1.42%) while the 
dashed lines show the upper (27.6%) and lower (-30.4%) limits of agreement. 
 
Testing of the model on the datasets from the last minutes of provoked sweating and of 
relaxation gave parallel (slope difference of 0.03) trend-lines with a bias of 0.28 μL. The 
lower R2 for the relaxation dataset is due to a reduced range in sweating.   
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Figure 5. Scatterplots of sweating estimated by the SCpos+AUC SP+AUC SB model for 
periods of provoked sweating (●) and relaxation (○). 
 
Discussion 
The results from this study show that there was a high temporal correlation between sweat 
rate and SC, that inclusion of SV and SB parameters could explain some of the between-
subjects variance, and that sweat production could be estimated with 12.9% average error by a 
model using a combination of the sum of SC increases, the SP and the SB areas under the 
curves.  
The high temporal correlation between Swr and SC within subjects was not entirely expected 
in spite of the agreement with Muthny21 and Edelberg8. Most previous studies have compared 
changes in evaporation to SC or SP during single sweat gland responses. A high correlation in 
this sense should lead to a similar correlation in this study assuming that both processes are 
equally linearly or non-linearly additive. Inspection of figure 1 suggests that this does not 
hold completely, as the SC tends to rise sharper and plateau earlier than the Swr. This could 
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be due to a reduction in SC as the skin is hydrated, leading to swelling of the stratum corneum 
and sweat pore closure, an effect explained in Edelberg 199310. It is also known that 
evaporation follows the electrical response by roughly 5s 22,16. The last factor to consider is 
the responsiveness of the QSweat device used to measure Sw in this study, which may have 
provided slow recordings despite the backwards filtering correction and due to the necessary 
aggressive low-pass filtering. 
The interindividual correlation between sweating and SC was not as high (r=0.49), in 
agreement with both Edelberg 8 (r<0.50) and Muthny 21 (r=0.23 to 0.64), although significant 
(p<0.01). Stronger correlations were found between sweating and the sum of SC increases 
and the number of these responses (NSCR). In agreement with Ellaway 12, the positive SP 
responses correlated better with sweating than the negative SP responses.  
Some indications of parameter redundancy could already be seen from table 2 with the 
combinations AUC SC+NSCR, AUC SC+SCpos, NSCR+SCpos and SPpos+SCpos. 
Multilinear regression including all parameters produced an overfitting with R2=0.84 which 
was reduced to 0.82 through elimination of the insignificant model parameters NSCR, SPpos 
and SPneg by means of stepwise regression. Validation of the suggested model from the 
stepwise regression by bootstrapping lead to elimination of also AUC SC. The remaining 
terms of SCpos+AUC SP+AUC SB was able to estimate total sweat production with a median 
R2=0.66 and median rmse error of 2.28 μL, which represents 15.4% of the measurement range 
or 8.7% of the QSweat device range, from validation by bootstrapping. We believe that the 
magnitude of this error needs to be considered with respect to the intended use. This accuracy 
is nevertheless a significant improvement compared to conventional SC measurement 
(Bootstrap validation of a model based on only AUC SC gave R2=0.09). The approximately 
±30 limits of agreement between measured and estimated sweating (figure 4) is also difficult 
to evaluate due to lack of similar studies. As an example, within cardiac output measurements, 
a limit of agreement up to ±30% has been suggested to be acceptable 6. This study may also 
be compared with Gagnon et al 13, where sweat gland activation was determined by a 
modified iodine-paper technique, in which a computerized method was compared with 
manual counts by the correlation coefficient and a Bland-Altman plot with the results of 
r=0.77 and ±38 glands/cm2 limits of agreement in a pool with a 70 glands/cm2 mean.  
The limits of agreement and the ICC can provide inconsistent results in agreement studies, 
and both are reported here according to the recommendation of 5. Similar to the Pearson’s r, 
an ICC close to 1 indicated ‘excellent’ reliability, but no agreement exists on the 
interpretation of the ICC. A value >0.9 has been proposed as high agreement between 
measurements, with an ICC between 0.7 and 0.8 representing questionable agreement in 
sports medicine 1. Within psychometrics, ICCs >0.75 to >0.81 have been suggested as 
excellent agreement 4, 2, 31. Portney and Watkins 25 suggested 0.75 as a threshold from ‘poor to 
moderate’ to ‘good’ reliability. Thus, we suggest that the ICC=0.84 in this study represents 
‘good’ reliability between measured sweating and what could be estimated from model.  
The same dataset was used to develop and to test the model in this study. Although the dataset 
was randomly divided in training and test sets in the bootstrap validation, all measurements 
were done by the same operators using the same methods and equipment on different subjects, 
hence this study does not assess repeatability or reproducibility. The ICC and the Bland-
Altman plot, being based on an estimation from the mean model coefficients from the 
bootstrapping, is a best-case representation of the agreement.  
There are numerous advantages of using the electrical methods in favor of the evaporative, as 
it enables miniaturization 27 and long-term ambulatory recording 24, lower costs of production 
and is much less susceptible to movement artifacts as the water loss measurement method 
requires a constant contact pressure of the probe onto the skin 23. We believe that the proposed 
method is useful for measurements of sweat production for both intra- and interindividual 
comparisons in situations where variations are large. Examples of such large variations 
include before-after treatment or treatment vs control of hyperhidrosis, exercise physiology 
studies, night-sweats, or psychological studies involving moderate to strong stressors.  
Validation of the model during stress and relaxation periods gave a bias in the scatterplot 
(figure 5) intercept of 0.28 μL, indicating that the model slightly (approx. 10%) overestimates 
the Sw during heavy sweating. This could be due to a slightly nonlinear relation between the 
electrical and evaporative changes, and suggests that a more advanced model should be 
considered based on a larger range in Swr, which was limited in this study due to the 
measurement range of the QSweat® device. The slopes for sweating during stress and 
relaxation however, were parallel, indicating that the model’s explanation of between-subjects 
variance is valid in both cases. 
The SC alone had a strong correlation to the individual variations, but both the SB and SV 
significantly helped explain the between-subjects factors, also with positive signs of their 
linear model coefficients. As mentioned in the introduction, the SB is known to reflect the 
moisture content of the stratum corneum separately from the sweat duct filling, and the water 
uptake of the corneum is known to differ among individuals 26. The SP contribution is more 
difficult to interpret, as the relation between SC and SP have previously been studied only to 
small extent due to lack of methods to measure them simultaneously. Contrary to the SC and 
SB, the palmar SP is negative with respect to an electrodermally inactive skin site and 
increases initially in the negative voltage direction when a sweat gland response occurs, but 
may shortly be followed by a response in the opposite direction towards 0V. A positive SP 
model coefficient thus means that sweat production is estimated to increase as the SP 
approaches zero. In view of figure 1, SC and SP (with an opposite sign) seems to correlate 
well during the relaxation intervals, but as sweating increases, the SP reacts in both directions, 
giving a very different change in the area under curve than for the SC. Along with the low 
between-subjects correlation between the two parameters (r=0.02), the results suggest that the 
two parameters bring complementary physiological information on the skin and sweating. The 
results in total speak in favor of utilizing simultaneous recording of SC, SP and SB for 
electrical measurement of sweat activity. 
The results indicate that roughly 30% of the interindividual variance in sweating could not be 
explained by the electrical parameters. The electrolyte concentration of sweat will directly 
influence the magnitude of the SC and SP responses, and relatively large variations in Na and 
K concentrations have been reported among healthy adults (51.9±21.1 meq for males, 
36.5±18.7 meq for females, mean±std.dev) 17. A sweat collector attached to the skin 
performing continuous conductivity measurement within a fixed volume could be included in 
order to increase the accuracy of the electrical measurement of sweating, and was considered 
in the planning of this study. Piloting however, revealed that insufficient amounts for analysis 
were collected during the experimental session when testing the Macroduct™ Sweat 
Collector. Another factor is the thickness of the corneum, which will influence both the Sw 
and electrical measurement, but in different ways. Egawa et al 11 reported a std.dev of 37 μm 
from a 173 μm mean for palmar corneum thickness. Only palmar skin was measured in this 
study, which is different from non-glabrous skin with respect to innervation, sweat gland 
count 20, corneum thickness 11, and electrical properties 7, 29. Due to these differences, the 
model will not likely be valid on non-palmar skin without new calibration. A future study is 
suggested including sweat electrolyte concentration measurement, measurements of larger 
ranges in Swr, and SC, SP and SB at additional skin sites with different corneum thickness, 
and repeated measurements over different seasons in order to assess the repeatability of the 
estimation.  
In conclusion, estimation of sweating, defined as water loss from the skin, is significantly 
improved by the addition of SB and SP measurement to the SC measurement only, yielding a 
model for estimation of sweating with approximately 15% average error.  
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Abstract 
Hepatic artery (HA) and portal vein (PV) occlusion are the most common vascular 
complications after liver transplantation with impact on mortality and re-transplantation rate. 
Detection of severe hypoperfusion may be delayed with currently available diagnostic tools. 
Hypoperfusion and anaerobically produced lactic acid lead to tissue CO2 increase. We aimed 
to investigate if continuous assessment of intrahepatic and intra-abdominal PCO2 may detect 
and distinguish HA and PV occlusion in real-time. 
 
In thirteen pigs HA and PV were fully (n=7) or gradually (n=6) occluded. PCO2 was 
monitored intrahepatically and between loops of small intestine. Hepatic and intestinal 
metabolism was assessed by microdialysis, portal and hepatic vein blood samples and 
compared to clinical parameters of systemic circulation and blood gas analysis. 
 
Total HA occlusion led to significant increases of hepatic PCO2 and lactate, 
accompanied by significant PO2 and glucose decrease. PV occlusion induced significant 
intestinal but not hepatic PCO2 increase along with significant intestinal increase of lactate 
and glycerol. Gradual HA and PV occlusion caused steady hepatic and intestinal PCO2 
increase, respectively. Systemic clinical parameters like blood pressure, heart rate and 
cardiac output were affected only by PV occlusion. 
 
In conclusion, even gradual occlusion of HA affects liver metabolism and is reliably 
identified by hepatic PCO2 measurement. Intestinal PCO2 increases only during PV occlusion. 
A combination of hepatic and intestinal PCO2 measurement reliably diagnoses the affected 
vessel, depicts the severity of the occlusion and emerges as a potential real-time clinical 
monitoring tool in the postoperative course of liver transplantation, enabling early intervention. 
 
249 words  
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Introduction 
 
Vascular complications in the course of orthotopic liver transplantation (OLT) lead to 
liver ischemia, which might constitute a life-threatening state for both patient and allograft (1, 
2). Hepatic artery (HA) stenosis and occlusion is the most common complication (incidence in 
adults up to 12%, in children up to 40%) (1), demands retransplantation in > 50% of all cases 
and is associated with a high mortality (3, 4). The incidence of portal vein (PV) obstruction is 
1-2% (1, 2), higher in patients with splanchnic thrombosis prior to OLT (up to 15%) (5), and 
carries a high morbidity and mortality (2).  
 
The high impact of vascular occlusion on mortality and retransplantation rates 
underscores the importance of early detection of vascular complications in the first week after 
transplantation when most of the vascular insults occur (3). Current standard of care is arterial 
blood lactate assessment, Doppler ultrasound and laboratory liver enzyme assessment daily 
(6). However, regular blood lactate measurement is not carried out after arterial line 
withdrawal.  Furthermore, there is no consensus on the frequency and timing of Doppler 
ultrasound, the method does currently not allow continuous monitoring and cannot reliably 
assess whether blood flow decrease is detrimental to the graft (3). Liver enzyme release 
reflects hepatic cell damage, is thus unspecific with respect to the cause and increases 
several hours after the vascular occlusion has occurred (3). Accordingly, detection of severe 
hypoperfusion may be delayed and as a consequence irreversible graft injury may be 
inevitable.  
 
Various experimental approaches aiming at continuous surveillance of hepatic 
metabolism have been evaluated for early detection of liver ischemia. Microdialysis was 
successfully used in liver transplant patients (7-9) and could detect liver ischemia by 
increasing lactate levels (8, 9). However, hepatic microdialysis was only capable in detecting 
HA and not PV occlusion in a porcine model (10) and clinical studies (9). Continuous 
measurement of hepatic oxygen and carbon dioxide partial pressure (PO2, PCO2) in animals 
was shown to be feasible and detected liver hypoxia and ischemia in models of global 
hypoxia (11) and hemorrhagic shock (12, 13). Likewise, intestinal PCO2 was shown to reflect 
intestinal ischemia (13). 
 
Tissue PCO2 increase reflects organ hypoperfusion, predicts organ failure and serves 
both as a measure of anaerobic metabolism (PCO2 is produced when bicarbonate buffers 
protons) and blood flow stagnation (impaired removal of both aerobically and anaerobically 
produced PCO2) (13-16).  
 
In a prior study, we evaluated a new miniature PCO2 sensor (IscAlert) in a model of 
myocardial ischemia/reperfusion and could report that ischemic episodes were successfully 
identified (17). The results challenged us to consider whether the FDA approved IscAlert 
sensor could also be used for detection of hepatic and intestinal ischemia. Neurotrend 
sensors and microelectrodes were used to verify IscAlert obtained values and to obtain tissue 
PO2 values. 
 
In this study, we aimed to evaluate PCO2 as a real-time diagnostic tool to detect HA 
and PV occlusion. We hypothesized (a) that intrahepatic and intraperitoneal PCO2 
measurement enables distinct detection of and discrimination between HA and PV occlusion 
in real time and (b) that even gradual HA and PV occlusion leads to metabolic changes 
reflected by PCO2 raise in liver and intestine, respectively.  
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Materials and Methods 
Experimental setup 
The Norwegian Animal Care and Use Committee approved the following protocol and 
animals were handled according to local guidelines and the Revised Guide for the Care and 
Use of Laboratory Animals (NIH GUIDE, 1996). 
 
Thirteen conventional landrace pigs (sus scrofa, Noroc), mean weight 59.3 kg (range 
54 – 62.5 kg), male or female, without any signs of infection were anesthetized by 
intramuscular injection of ketamine (30 mgkg-1) and azaperone (3 mgkg-1). Anesthesia and 
analgesia were maintained by continuous isoflurane (1-1.5% inspired fraction) and infusion of 
morphine (0.5-1 mgkg-1h-1). 
 
After tracheotomy, mechanical ventilation (Servo ventilator system 900 C, Siemens, 
Germany) was carried out with a mixture of room air and oxygen aiming to keep arterial PO2 
above 90 mmHg (12 kPa). Tidal volume and ventilation rate were adjusted to keep arterial 
PCO2 close to 40 mmHg (5.5 kPa).  
 
One catheter was inserted in the right internal jugular vein for intravenous injection 
and measurement of central venous pressure, another catheter in the right carotid artery for 
assessment of arterial blood pressure and arterial blood sampling. Cardiac index (CI) was 
obtained from a femoral artery PiCCO catheter, (PULSION Medical Systems, Munich, 
Germany) after thermal dilution calibration.  
 
After median laparotomy the PV and HA proximal to splitting into lobe arteries were 
identified in the portal hiatus of the liver.  Blood flow measurement using transit time flow-
probes (PeriVascular probe, MediStim, Oslo, Norway) was established. Inflatable vascular 
occluders (In Vivo Metric, Healdsburg, CA, USA) were placed around the PV and HA. It was 
assured that the deflated occluder did not reduce blood flow and that maximal inflation totally 
obliterated blood flow. Regulation of the grade of occlusion was achieved using a manually 
adjustable syringe pump.  
 
Catheters enabling blood sampling from the PV and hepatic vein (HV) were 
established using the Seldinger technique by penetrating the peripancreatic fat and anterior 
middle liver lobe, respectively.  
 
Four to six miniature sensors (<1 mm diameter) measuring PCO2 (IscAlert, 
SensoCure AS, Horten, Norway) were placed in the liver via a split needle 5 - 10 mm below 
the surface. Up to three sensors were freely placed into the abdominal cavity, lying in 
between loops of small intestine. IscAlert sensors detect changes in PCO2 from an 
automatically calculated baseline at zero based on a conductometric method described 
elsewhere (18). Briefly, a gas-permeable membrane allows tissue CO2 diffusion into the 
water-filled sensor where CO2 dissolves to HCO3- and H+. This leads to a change in the 
conductivity of the water, which is continuously measured by the electrical impedance 
between two electrodes in the sensor.  
 
To verify the IscAlert derived PCO2 changes and to obtain tissue PO2 values a fiber-
optical sensor measuring tissue PO2, PCO2 and temperature (Neurotrend®, Codman, MA) 
was inserted into the anterior middle lobe of the liver in the same manner as the IscAlert 
sensors. Neurotrend sensors do not tolerate intestinal movements, which can lead to bending 
of the sensors’ optical fibers. Thus, three dip-type CO2 microelectrodes (Microelectrodes Inc, 
Bedford, NH, USA) were placed in the abdominal cavity in two animals for comparison to 
IscAlert obtained values. 
 
Up to three microdialysis catheters (CMA 65, 100 kDa cutoff, 3 cm membrane, 1 
μlmin-1 flow, M Dialysis, Solna, Sweden) were inserted in the proximity of the Neurotrend® 
and IscAlert sensors in the liver and up to two were placed intraluminally into the jejunum. 
Microdialysis allows determination of tissue levels of substances important in cellular 
metabolism. The microdialysis catheter consists of a semi-permeable membrane with a 
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defined pore-size allowing recovery of substances from the tissue. Tissue metabolites 
equilibrate into a dextrane containing fluid (Plasmodex, Meda AB, Solna, Sweden) on the 
inner side of the membrane. The fluid is pumped continuously into a collection tube (microvial, 
M Dialysis, Solna, Sweden). The collection tube is disconnected for analysis of lactate, 
glucose, pyruvate and glycerol in an analysis machine (CMA 600, M Dialysis, Solna, Sweden).   
 
After instrumentation the abdomen was loosely closed using surgical metal clamps 
preventing temperature decline and excessive fluid loss due to perspiration, while allowing 
intermittent observation of the liver and intestine. The abdominal wall was elevated using a 
lifting bandage to avoid increased intraabdominal pressure.  
To compensate for fluid loss due to surgery and basic metabolism crystalloids were 
administered at 10 - 13 mlkg-1h-1 to achieve isovolemia as judged by central venous pressure 
(4-12 cm H2O), cardiac index (< 10% change), urine production (> 1 mlkg-1h-1) and hematocrit 
(< 5% change). Blood glucose was regularly measured and glucose 10% was infused to 
ensure normoglycemia. Events of acute circulatory instability occurred in the course of PV 
occlusion and pigs were resuscitated with colloid infusion and continuous as well as bolus 
administration of epinephrine. 
 
Experimental protocol 
Following a one hour stabilization period after surgery, subjects were assigned to 
either group A (7 subjects) or B (6 subjects). In group A, the HA was fully occluded for 30 
minutes (min) followed by a 30 min reperfusion period (fig. 1). Thereafter PV was fully 
occluded for 30 minutes (min) followed by a 60 min reperfusion period. Both HA and PV were 
then gradually occluded to 60, 40, 30, 20, 10, and 0% blood flow with a duration of 30 min at 
each level (fig. 1).  
 
In group B, hepatic artery baseline flow was recorded and thereafter gradually 
reduced to 60, 40, 30, 20, and 10% flow in 20 min steps and was held fully occluded for 60 
min. After a 60 min reperfusion period the portal vein was gradually occluded in the same 
manner and 0% flow was maintained for 20 min (fig. 1). 
 
 
Figure 1 - Schematic time-line of the experimental design.  
Blood flow was reduced in HA (dotted line) and PV (dashed line) for the designated intervals 
in group A (seven animals) and B (six animals). 
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Data collection 
Global variables of circulation and respiration as well as data collected from the 
Neurotrend sensor were continuously recorded every 20 seconds using ICUpilot® software 
(M Dialysis, Solna, Sweden). IscAlert, Microelectrodes and blood flow data were acquired 
continuously every 20 seconds using LabView® software v8.5. Arterial, portal vein and 
hepatic vein blood samples were drawn for blood gas analysis (ABL 800, Radiometer 
Copenhagen, Denmark) at baseline, 5 min before each new occlusion, and at the end of the 
last reperfusion period. Microdialysis samples were obtained at the same time points and 
analyzed for tissue lactate, glucose and glycerol (CMA 600, M Dialysis, Stockholm, Sweden).  
 
In the seven animals of group A IscAlert catheters were used in four animals because 
of sensor production stop. In the same group, data from Neurotrend sensors was used from 
six animals because of catheter malfunction in one animal. One subject in group A became 
cardiovascular instable after portal vein occlusion with subsequent death and data for 
combined HA and PV occlusion therefore consists of 3 IscAlert datasets. All animals in group 
B were monitored with both IscAlert and Neurotrend sensors in liver and intestine.  
 
Arterial blood samples were drawn at baseline, at the end of each reperfusion period 
and at the end of 0% flow in HA and PV for analyses of bilirubin, aspartate-amino-transferase 
(AST), alanine amino-transferase  (ALT), lactate-dehydrogenase (LDH), alkaline phosphatase 
(ALP) and gamma-glutamyl-transferase (J-GT). 
 
Statistics 
Pilot experiments in animals undergoing identical anesthesia, surgery and insertion of 
measurement devices but without vascular occlusion revealed no changes in parameters of 
cardiovascular function or intra-organ metabolism when observed for as long as the 
experiment lasted in this study. Based on these findings we decided that a control group 
would be unnecessary both for ethical and economic reasons and reduction in the number of 
animals used. Thus, each animal serves as its own control and values at the end of the 
stabilization period and prior to gradual occlusion of HA, PV or both were used as controls for 
each parameter in order to monitor biological changes. Maximum values during the 
experimental events were extracted for all parameters measured continuously (IscAlert, 
Neurotrend, systemic parameters). Statistical differences were tested using a linear mixed 
effect model. A random effects model was used and model selection was done for each 
variable by choosing the model achieving the lowest Information Criteria. The measured 
parameters were dependent variables, vascular occlusion events were assigned fixed effect 
and the random effects of subjects and groups were included in the model. A post-hoc 
comparison of all groups to baseline with Bonferroni correction for multiple testing was 
performed. A P-value ≤ 0.05 was considered statistically significant. Statistical analysis was 
done with SPSS 18 (IBM, Armonk, NY, USA). Graphs were prepared with SigmaPlot 11 
(Systat Software Inc., San Jose, CA, USA) and GraphPad Prism 5 (GraphPad Software Inc., 
La Jolla, CA, USA).  
 
Results 
 
Hepatic and intestinal PCO2 and PO2 
In group A, total HA and PV occlusion was reliably achieved (fig. 2). HA occlusion led 
to significant hepatic PCO2 increase detected by both hepatic IscAlert and Neurotrend 
catheters (P < 0.001 and 0.02, respectively, fig. 2 A). PCO2 in the abdominal cavity remained 
unchanged (fig. 2 B). During PV occlusion, intestinal PCO2 increased and was reliably 
detected by IscAlert (P = 0.02) and Microelectrode sensors (fig. 2 B). Hepatic PCO2 increased 
slowly, but non-significantly during 30 min of PV occlusion (fig. 2 A). After reopening of the PV 
occlusion, intestinal PCO2 began immediate return to baseline, while hepatic PCO2 increased 
before approaching baseline values after 15 min. 
During both HA and PV total occlusion, hepatic PO2 decreased significantly (P < 
0.001) (fig. 2 A). Anoxia was neither achieved during HA nor PV occlusion.  
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Figure 2 – HA and PV occlusion are detected by PCO2 measurement 
Blood flow in HA (black line) and PV (grey line) was reliably reduced to zero during occlusion. 
(A) HA occlusion but not PV occlusion led to significant increase of hepatic PCO2 from 
baseline measured by IscAlert (; maximum change 9 mmHg (1.2 kPa)) and Neurotrend (†; 
maximum change 13 mmHg (1.7 kPa)). Both HA and PV occlusion led to significant reduction 
in hepatic PO2 (‡). (B) Intestinal PCO2 was significantly augmented only during PV occlusion 
and not HA occlusion as detected by IscAlert sensors (#; maximum change 43 mmHg (5.7 
kPa)). 
PCO2 values expressed as median (black lines) and quartile range (grey lines). Blood flow 
and PO2 are expressed as median. P ≤ .05, exact values presented in text. 
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Hepatic and intestinal metabolism 
 
Hepatic microdialysis in the course of HA occlusion revealed significant lactate 
increase (P = 0.003), accompanied by significant glucose decrease (P = 0.01; fig. 3 A). 
Glycerol showed a non-significant increasing trend (P = 0.21). During PV occlusion, hepatic 
glucose was unaffected while lactate increased significantly (P = 0.002).  
 
Intestinal metabolism was not affected by HA occlusion, reflected by unchanged 
intraluminally assessed microdialysis samples (fig.  3 B). Abrogation of PV blood flow caused 
significant increases in intraluminal lactate (P < 0.001) and glycerol (P = 0.004, fig. 3 B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Intermediate metabolism in liver and intestine is affected by HA and PV occlusion 
(A) Hepatic microdialysis showed significant reduction of glucose and elevation of 
lactate during HA occlusion accompanied by a non-significant glycerol increase. PV occlusion 
led to significant hepatic lactate increase, while all other parameters were unchanged. (B) HA 
occlusion did not influence intestinal homeostasis. PV occlusion led to significant increases in 
intestinal lactate and glycerol. 
All values presented as mean ± S.D.; :p ≤ .05, exact values presented in text. 
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Blood gas analysis and laboratory assessment of hepatic 
cell damage 
Blood gas analysis from PV, hepatic vein (HV) and arterial blood samples revealed 
that only PV occlusion and the following reperfusion led to significant and clinical relevant 
changes in PCO2, lactate and oxygen saturation at all measurement sites (table 1).  
 
Table 1 Blood Gas Analysis 
 
All values: Mean ± S.D.; SO2: saturation of oxygen  
: p ≤ 0.05, Linear mixed-effects model with post-hoc comparison of all samples to baseline 
and Bonferroni correction for multiple testing 
 
Laboratory assessment of standard clinical parameters for liver cell damage showed 
a significant AST increase from baseline (40.0 ± 9.5 U/l) in the course of PV occlusion (95.0 ± 
52.2 U/l, P = 0.006) and PV reperfusion (123.3 ± 43.3 U/l, P < 0.001), while bilirubin, ALT, 
LDH, ALP and J-GT remained unaffected and in the normal range throughout the experiment. 
 
Systemic hemodynamics 
While complete occlusion of HA had no effect, total obstruction of PV did significantly 
change mean arterial blood pressure, heart rate, end-tidal CO2 and CI (P < 0.05; table 2). 
 
Table 2 Systemic Parameters 
 
All values expressed as mean ± SD of the average in the evaluated period; MAP: mean 
arterial pressure; CI: cardiac index; SpO2: saturation of peripheral oxygen; etCO2: end tidal 
CO2 
*: p ≤ 0.05, Linear mixed-effects model with post-hoc comparison of all samples to baseline 
and Bonferroni correction for multiple testing 
 
Experimental clinical situations 
Acute total HA or PV obstruction may occur clinically as embolization or thrombosis. 
Gradual stenosis also occurs due to graft kinking or incomplete thrombosis, leading to total 
obstruction after some time. Hence, HA and PV were gradually occluded separately (fig. 4 A 
& B) or in combination, the latter resembling systemic blood flow impairment as seen in 
cardiogenic or hemorrhagic shock (fig. 4 C). Gradual HA blood flow decrease led to a step-
wise increase in the hepatic PCO2, while intra-abdominal PCO2 was unchanged (fig. 4 A). 
Event MAP (mmHg) 
CI 
(l/min/m2) 
Pulse 
(beats/min) 
SpO2 
(%) 
etCO2 
(mmHg) 
Baseline 66.8 ± 7.8 4.2 ± 0.7 85.3 ± 13.3 99.7 ± 0.4 47.3 ± 4.5 
Hepatic artery 
occlusion 70.3 ± 11.3 4.1 ± 0.8 85.7 ± 15.3 99.4 ± 0.9 47.3 ± 4.5 
Reperfusion 66.2 ± 8.2 4.5 ± 0.8 90.3 ± 18.7 99.3 ± 0.9 47.3 ± 3.8 
Portal vein 
occlusion 51.2 ± 9.7  3.2 ± 1.0  116.1 ± 29.4  99.6 ± 0.5 42.0 ± 6.8  
Reperfusion 66.5 ± 8.5 5.1 ± 0.7 121.6 ± 11.0  98.1 ± 1.5 48.0 ± 3.8 
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Gradual PV blood flow reduction led to an immediate increase of intestinal PCO2 with each 
reduction in blood flow (fig. 4 B). Combined graded HA and PV blood flow reduction led to 
joint increases of hepatic and intestinal PCO2 reaching high end-point values (fig. 4 C). 
Hepatic lactate determined by microdialysis remained unaffected during gradual HA blood 
flow reduction (data not shown). PV and combined HA and PV obstruction caused immediate 
intestinal and hepatic lactate increase attaining significance during 10% and 0% blood flow 
(data not shown).  
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Figure 4 – Gradual blood flow decrease in HA, PV or both is detected by hepatic and 
intestinal PCO2 measurement with IscAlert sensors 
Blood flow in HA (black line) and PV (grey line) was reliably reduced to target values 
expressed as percentage of baseline blood flow. (A) Gradual decrease of HA blood flow 
resulted in hepatic PCO2 increase (continuous line), reaching significance during 40% of 
baseline blood flow (; maximum change from baseline 8 mmHg (1.1 kPa)), while 
intraperitoneal PCO2 (dash-dot line) was unaffected. (B) PV occlusion did not affect hepatic 
PCO2 but intra-abdominal PCO2 was significantly increased starting at 20% blood flow (#; 
maximum change from baseline 39 mmHg (5.2 kPa)). (C) Combined flow reduction in HA and 
PV resulted in significant intestinal (#; maximum 50 mmHg (6.6 kPa)) and hepatic (; 
maximum 36 mmHg (4.8 kPa)) PCO2 increase with the highest end-point values of all 
situations tested. PCO2 values expressed as median (black lines) and quartile range (grey 
lines). Blood flow is expressed as median. P ≤ .05, exact values presented in text. 
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Discussion 
 
In the present study, we demonstrate that selective occlusion of HA and PV leads to 
distinct alterations of hepatic and intestinal metabolism, respectively. HA occlusion affects 
hepatic energy metabolism resulting in glucose depletion, lactate and PCO2 increase, while 
intestinal metabolism is unaffected. PV occlusion mainly affects intestinal metabolism leading 
to intraluminal increases in lactate and glycerol concomitant with an intra-abdominal PCO2 
increase. Gradual occlusion of either HA and PV alone or in combination results in specific 
PCO2 changes in both liver and intestine already during states of impaired blood flow.  
 
We detected a significant increase in hepatic PCO2 during HA occlusion and HA 
stenosis when blood flow was reduced to 40% of baseline. Intestinal PCO2 increased only 
during PV occlusion. PCO2 increase might be either due to blood flow stagnation leading to 
accumulation of aerobically produced CO2 or anaerobic metabolism leading to CO2 
generation by bicarbonate buffering lactate derived protons (16, 19). During complete blood 
flow obstruction, our study supports the latter cause since simultaneous lactate and glycerol 
increase indicate ischemia with cellular membrane break down. States of diminished blood 
flow during gradual obstruction did not lead to hepatic nor intestinal lactate increases, 
probably due to pre-conditioning effects of slow and stepwise reduced blood flow (20). 
Reduced HA and PV blood flow, however, caused hepatic and intestinal PCO2 increase, 
respectively, strongly indicating that blood flow stagnation contributes to the accumulation of 
CO2 in the organ (16). PCO2 in the HV showed a modest increase during HA and PV 
occlusion. Greater de-oxygenation of hemoglobin during hypoxia alkalinizes hemoglobin, thus 
increasing proton buffering ability as well as binding of CO2 forming carboxyhemoglobin 
(Haldane effect). This effect enables transport of large amounts of CO2, while dissolved 
venous effluent PCO2 gets only minimally increased (21). Blood gas analysis measures the 
dissolved portion of CO2 and the increase in tissue PCO2 will therefore be more pronounced 
than the increase in HV PCO2. Tissue PCO2 may thus serve as a parameter of blood flow 
assessment with slower and lower increase during blood flow decrease and fast and higher 
elevation during states of tissue ischemia (13). 
 
Standard clinical monitoring using parameters of systemic hemodynamic monitoring 
and arterial blood gas analysis failed to detect HA occlusion. PV occlusion led to significant 
changes of blood pressure, pulse, end tidal CO2 and cardiac output. These observations are 
unspecific as they reflect acute hypotension with compromised systemic circulation due to 
blood pooling in the intestine and would thus not result in reliable and exclusive diagnoses of 
acute PV occlusion. Only AST but not ALT and bilirubin got elevated during PV occlusion. 
This may imply that intestinal but not hepatic cell damage occurred (22) in accordance with 
AST being released during intestinal ischemia. However, the specificity of AST as a serum 
marker for intestinal ischemia is weak (23). The findings support the impression that 
postoperative HA and PV occlusions are difficult to detect with current standards of 
monitoring (1). Contrary to this, we show that continuous intraorgan monitoring using hepatic 
and intra-abdominal PCO2 measurement provides both real-time ischemia detection as well 
as identification of the affected vascular territory. 
 
Both HA and PV occlusion leads to comparable hepatic PO2 decrease as both 
vessels contribute to the hepatic oxygen content. Therefore, surveillance of hepatic PO2 does 
not seem to be optimal for monitoring of liver grafts as neither the metabolic state nor the 
affected vessel can be identified. Occurrence of anaerobic metabolism and significant PCO2 
increase seemed to be dependent on the lack of HA and not PV blood flow, confirming clinical 
and experimental findings (9, 10). Occurrence of anaerobic metabolism despite sufficient PV 
blood flow might be explained by the fact that parts of the liver, e.g. the biliary system, are 
dependent on HA blood flow (4, 24).  
 
Recently, post-operative monitoring of the liver graft using microdialysis has been 
successfully evaluated in both experimental and clinical studies and was shown to detect 
acute cellular rejection and HA occlusion (8-10). In this study, we confirm that HA occlusion 
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leads to significant lactate production already after 30 min and is accompanied by PO2 
decrease and PCO2 increase, indicating that lactate production is indeed due to anaerobic 
metabolism rather than hyper-metabolism as seen in rejection (10). PV occlusion affected 
intestinal metabolism and it has been shown that intestinal ischemia leads to dysfunction of 
the gut barrier resulting in luminal lactate and glycerol increase (25, 26). Microdialysis 
catheters placed between loops of intestine have been shown to reflect the intraluminal 
changes (26, 27). Results from the present study might therefore be translated to clinical 
monitoring with placement of the microdialysis catheters or IscAlert sensors between 
intestinal loops for reliable detection of intestinal ischemia.  
 
PV occlusion lead to significant hepatic lactate increase, which was not observed in a 
different model where a portocaval shunt was used during PV occlusion (10). The 
discrepancy could be explained by the portocaval shunt preventing intestinal venous 
congestion; while in our model blood stasis and pooling in the intestine lead to intestinal 
ischemia with lactate production and assumed shunting to the systemic circulation. In addition 
to physiological and therefore normal shunts patients with portal hypertension have 
established collaterals pre-transplantion (28). However, these collaterals are probably not as 
efficient as an experimental portocaval shunt during postoperative PV occlusion. Thus, PV 
occlusion after OLT will lead to some degree of intestinal venous congestion with subsequent 
intestinal ischemia, lactate and PCO2 increase (29).  
 
Following liver transplantation, the most important property of a test is the ability to 
detect impaired hepatic artery circulation, since this is the most deleterious and common 
vascular complication. Consequently, both microdialysis and PCO2 monitoring could be useful 
to detect and discriminate HA and PV occlusion. Currently, microdialysis has the advantage 
of clinical approval, at least in Europe. However, the additional workload of substance 
analysis combined with considerable price and uncertainty of individual catheter life span may 
limit future clinical application in liver transplants. IscAlert PCO2 sensors on the other hand 
would have the advantage of real-time, bedside continuous monitoring without increased 
workload. Most importantly, based on our results partially decreased blood flow would be 
detected only with IscAlert sensors, while full occlusion would be detected earlier with IscAlert 
sensors than with microdialysis catheters.  
 
Limitations of this study include the large variance of systemic circulatory function 
during PV occlusion. However, as the trend of all measured variables was consistent, 
statistical significance was achieved. We did not evaluate hepatic and intestinal PCO2 during 
hepatic vein occlusion, a rare clinical condition caused by veno-occlusive disease or caval 
stenosis (1, 30). One might speculate that total hepatic vein occlusion would lead to PCO2 
rise in both liver and intestine due to blood congestion and tissue ischemia but further studies 
should explore this disease entity.  Currently, none of the investigated PCO2 sensors are 
approved for hepatic or intestinal use. Neurotrend sensors are neither produced nor 
commercially available, while Microelectrodes are not approved for clinical use. The IscAlert 
sensor is FDA approved for use in human skeletal muscle, and approval for intraabdominal 
use will be sought. The IscAlert sensor design has good functionality, as they were easy to 
insert in both liver and abdominal cavity, did not lead to bleeding or other adverse effects and 
were easy to retract without damage of the liver tissue at the end of the experiment. 
 
Clinical studies will be carried out with IscAlert PCO2 sensors inserted in the liver at 
the end of the transplantation surgery. Intestinal sensors could either be left in the abdominal 
cavity at the end of surgery, or inserted percutaneously under ultrasound guidance via a split-
needle technique (27).  
 
In conclusion, continuous real-time intraorgan monitoring of liver and intestinal PCO2 
evolves as a potential method to monitor hepatic and intestinal blood supply.  Vascular 
complications can be revealed almost immediately, which is clearly superior to current 
monitoring methods. Combined hepatic and intra-abdominal sensor placement enables 
detection and discrimination of HA and PV occlusion.  
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APPENDIX 
ISSS 10th International Symposium on Sympathetic Surgery poster by Øvensen et al (by 
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